logo
Itafos Reports Outstanding Operational and Financial Q1 2025 Results

Itafos Reports Outstanding Operational and Financial Q1 2025 Results

Yahoo07-05-2025
Free cash flow 1 of $31.3 million in Q1 2025 compared to $17.7 million in Q1 2024.
Basic earnings of C$0.27/share in Q1 2025 compared to C$0.17/share in Q1 2024; and
Net income of $35.9 million in Q1 2025 compared to $23.7 million in Q1 2024;
Adjusted EBITDA of $39.3 million in Q1 2025 compared to $43.2 million in Q1 2024;
Revenues of $135.7 million in Q1 2025 compared to $128.0 million in Q1 2024;
For Q1 2025, the Company's financial highlights were as follows:
The Company was also pleased to announce the successful closure of the Araxa project sale during the quarter and the declaration of a special dividend associated with the sale. We remain committed to creating long-term value for our shareholders and will continue to evaluate additional value creation / capital return opportunities.'
During Q1 2025, the Company achieved a significant milestone when our net debt 1 was reduced to below $0 helping us weather the near-term market uncertainties and allowing us to continue to fund our capital requirements.
We continue to make progress on our mine life extension program at Husky 1 / North Dry Ridge ('H1/NDR') in Idaho and reiterate our expectation to deliver the first ore shipments to the Conda plant in the second half of this year. Uncertainty surrounding the US tariff policy and international trade flows have created volatility in commodity prices resulting in market prices increasing in Q2 2025 to date. These higher prices coupled with constructive long-term supply and demand fundamentals in phosphate markets continue to be positive for the performance of the Company. In the near term, higher product prices are likely to be largely offset by higher non controllable input costs (particularly sulfur) impacting gross margin realizations.
Chief Executive Officer David Delaney commented, 'the Company recorded another outstanding quarter from an operational perspective, with production volumes exceeding prior year levels at both Conda and Arraias. This was achieved without incurring a recordable incident at the Company. Our continued emphasis on safety and operational efficiency directly led to another strong quarter of financial results including revenue growth of 6 percent on a year-over-year basis and adjusted EBITDA 1 of over $39 million despite meaningfully higher non controllable input costs.
HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (the 'Company') today reported its Q1 2025 financial results and provided a corporate update. The Company's financial statements and management's discussion and analysis for the three months ended March 31, 2025 are available under the Company's profile at www.sedarplus.ca and on the Company's website at www.itafos.com . All figures are in thousands of US Dollars except as otherwise noted.
Story Continues
The decrease in the Company's Q1 2025 adjusted EBITDA compared to Q1 2024 was primarily due to higher input costs at Conda due to sulfur market dynamics, which were partially offset by higher revenues.
The increase in the Company's Q1 2025 net income compared to Q1 2024 was primarily due to the gain on sale of the Araxá project, as explained below, and lower finance expenses, which were partially offset by higher withholding tax expenses related to the sale of the Araxá project.
The Company's total capex1 spend in Q1 2025 was $9.9 million compared to $6.4 million in Q1 2024 with the increase primarily due to development activities at H1/NDR, magnesium oxide reduction initiatives at Conda, and activities related to the Fertilizer Restart program at Arraias.
As of March 31, 2025, the Company's financial highlights were as follows:
Trailing 12 months Adjusted EBITDA 1 of $155.6 million;
Net debt 1 of $(1.7) million; and
Net leverage ratio1 of (0.0)x.
________________________________
1Adjusted EBITDA, trailing 12 months Adjusted EBITDA, total capex, net debt, net leverage ratio and free cash flow are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see 'Non-IFRS financial measures' below. International Financial Reporting Standards ('IFRS').
Sale of the Araxá Project
On August 5, 2024, the Company entered into an agreement to sell its 100% interest in the Araxá project to a wholly-owned subsidiary of St George Mining Limited ('St George') (ASX: SGQ) in exchange for cash payments totaling $21 million (paid over time in three (3) tranches) and securities of St George (the 'Transaction'). As a result of the Transaction, St George indirectly acquired all of the outstanding securities of Itafos Araxá Mineração e Fertilizantes S.A. The Transaction closed on February 26, 2025. The Company recorded a gain on disposal of subsidiary of $27.9 million.
Recent Developments
On April 3, 2025, the Company received the vesting notice from St. George related to the 11,111,100 performance rights received from St. George as part of the Transaction; and
On April 25, 2025, the Company paid the C$0.05 per share special dividend to shareholders of record as of the close of business on April 9, 2025.
FY 2025 Market and Financial Outlook
Market Outlook
Phosphate pricing decreased marginally in Q1 2025 from elevated levels in the second half of 2024, consistent with seasonal factors moving into spring. Domestic pricing through Q1 has remained largely flat, though the Company has seen recent price increases in response to the potential impacts of tariffs on US phosphate imports. From the beginning of the second quarter, uncertainty surrounding US tariff policy and international trade flows have created volatility in commodity prices resulting in phosphate prices increasing.
Crop fundamentals remain constructive, with inventories of grains and oilseeds outside of China expected to decrease through the current crop year, resulting in a declining stock-to-use ratio that is projected to decline to levels comparable to those experienced during the food crises in 2007/2008. That being said, crop prices have been limited in appreciation due to the uncertainty around tariffs and international demand for US grain.
Moving forward, the Company expects phosphate pricing to remain strong through 2025, supported by the following factors:
Strong global demand for phosphates and increasing international prices;
Limited phosphate imports and subsequent limited supply into the US due to evolving tariff policies; and
Ongoing export restrictions from China.
Financial Outlook
The Company maintained its guidance for 2025 as follows:
(in millions of US Dollars
Projected
except as otherwise noted)
FY 2025
Sales Volumes (thousands of tonnes P 2 O 5 )2
340-360
Corporate selling, general and administrative expenses3
$17-20
Maintenance capex3
$13-23
Growth capex3
$63-83
Environmental and asset retirement obligations payments
$5-7
________________________________
2Sales volumes reflect quantity in P2O5 of Conda sales projections.
3Corporate selling, general and administrative expenses, maintenance capex and growth capex are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see 'Non-IFRS financial measures' below.
Q1 2025 Market Highlights
MAP New Orleans ('NOLA') prices averaged $596/st in Q1 2025 compared to $624/st in Q1 2024, down 4% year-over-year.
Specific factors driving the year-over-year decrease in MAP NOLA prices were as follows:
A measured price correction to align more closely with international market levels after a period of relatively elevated pricing; and
A relatively high volume of MAP imports into the US in Q4 2024 and Q1 2025.
March 31, 2025, Highlights
As of March 31, 2025, the Company had trailing 12 months Adjusted EBITDA of $155.6 million compared to $159.5 million as of December 31, 2024 with the decrease primarily due to the same factors that resulted in lower Adjusted EBITDA during Q1 2025 as compared to Q1 2024 described above.
As of March 31, 2025, the Company had net debt of $(1.7) million compared to $26.8 million as of December 31, 2024, with the reduction primarily due to higher cash and cash equivalents. The Company's net debt as of March 31, 2025 was comprised of $100.3 million in cash and $98.6 million in debt (gross of deferred financing costs). As of March 31, 2025 and the end of 2024, the Company's net leverage ratio was (0.0)x and 0.2x, respectively.
As of March 31, 2025, the Company had liquidity4 of $180.3 million comprised of $100.3 million in cash and $80 million in undrawn borrowing capacity under its $80 million asset-based revolving credit facility ('ABL Facility').
________________________________
4Liquidity is a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see 'Non-IFRS financial measures' below.
Operations Highlights and Mine Development
Environmental, Health, and Safety ('EHS')
For Q1 2025, the Company continued strong EHS performance, including no reportable environmental releases and no recordable incidents, which resulted in a consolidated TRIFR of 0.58.
Conda
In Q1 2025, Conda:
Produced 91,200 tonnes P 2 O 5 compared to 90,246 tonnes P 2 O 5 in Q1 2024;
Generated revenues of $128.3 million compared to $122.8 million in Q1 2024; and
Generated Adjusted EBITDA of $40.9 million compared to $46.6 million in Q1 2024 with the decrease primarily due to higher input costs.
Exploration and Appraisal Program at Conda
As capital work at H1/NDR continues with first ore shipments expected in 2H 2025, the Company is focused on identifying and pursuing opportunities to add additional resources and reserves to the project to extend mine life beyond the current NI 43-101 estimate of mid-2037. To pursue this objective, the Company has commenced a multi-year exploration, resource evaluation and permitting program at Conda with an expected annual cost of approximately $6-8 million.
The program is focused on further delineating upside potential of the Husky 1 Lease through resource delineation appraisal drilling at 250ft spacing (current spacing at 500ft), delineation drilling on the Dry Ridge Lease on 2400ft centers to gain crucial geologic and metallurgical information to be used in resource modeling that will drive future mine planning resource estimation and permitting studies. Core drilling and geologic modeling of the Husky 3 and 4 Leases is planned for late Q3/early Q4 2025 upon permit approval by Federal Agencies to identify resource potential for future mine development along the current mine trend.
In addition to these activities, work will commence on baseline resource studies required for future National Environmental Policy Act permitting and regulatory approvals. These near field opportunities have the potential to extend mine life beyond the current NI 43-101 estimate of mid 2037 in an efficient manner with the objective of utilizing the current infrastructure being built out at H1/NDR.
Arraias
In Q1 2025, Arraias:
Produced 37,701 tonnes of sulfuric acid compared to 33,216 tonnes in Q1 2024 driven by higher customer demand;
Produced 533 tonnes P 2 O 5 of DAPR and PAPR compared to 0 tonnes P 2 O 5 in Q1 2024, as activity commenced under the Fertilizer Restart Program; and
Generated Adjusted EBITDA of $2.0 million compared to $0.4 million in Q1 2024 with the improvement due to higher sulfuric acid sales volumes and gross margin and incremental P 2 O 5 volumes resulting from progress made under the Fertilizer Restart Program.
About Itafos
The Company is a phosphate and specialty fertilizer company with businesses and projects spanning three continents:
Conda – a vertically integrated phosphate fertilizer business located in Idaho, US, with the following production capacity: approximately 550kt per year of MAP, MAP with micronutrients ('MAP+'), superphosphoric acid ('SPA'), merchant grade phosphoric acid ('MGA') and ammonium polyphosphate ('APP') approximately 27kt per year of hydrofluorosilicic acid ('HFSA')
Arraias – a vertically integrated phosphate fertilizer business located in Tocantins, Brazil, with the following production capacity: approximately 500kt per year of single superphosphate ('SSP') and SSP with micronutrients ('SSP+') approximately 40kt per year of excess sulfuric acid (220kt per year gross sulfuric acid production capacity)
Farim – a high-grade phosphate mine project located in Farim, Guinea-Bissau; and
Santana – a vertically integrated high-grade phosphate mine and fertilizer plant project located in Pará, Brazil
The Company is a Delaware corporation headquartered in Houston, Texas. The Company's shares trade on the TSX-V under the ticker
'IFOS'. The Company's principal shareholder is CL Fertilizers Holding LLC ('CLF'). CLF is an affiliate of global private investment firm Castlelake, L.P.
For more information, or to join the Company's mailing list, please visit www.itafos.com .
Forward-Looking Information
Certain information contained in this news release constitutes forward-looking information, including statements with respect to: import and export tariffs; the Company's planned operations and strategies; the timing for the commencement of operations and first ore at H1/NDR; the expected resource life of H1/NDR; exploration activities to extend mine life; and economic and market trends with respect to the global agriculture and phosphate fertilizer markets. All information other than information of historical fact is forward-looking information. Statements that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future include, but are not limited to, statements regarding estimates and/or assumptions in respect of the Company's financial and business outlook are forward-looking information. The use of any of the words 'intend', 'anticipate', 'plan', 'continue', 'estimate', 'expect', 'may', 'will', 'project', 'should', 'would', 'believe', 'predict' and 'potential' and similar expressions are intended to identify forward-looking information.
The forward-looking information contained in this news release is based on the opinions, assumptions and estimates of management, some of which are set out herein, which management believes are reasonable as at the date the statements are made. Those opinions, assumptions and estimates are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual events or results to differ materially from those projected in the forward-looking information. These include the Company's expectations and assumptions with respect to the following: commodity prices; operating results; safety risks; changes to the Company's mineral reserves and resources; risk that timing of expected permitting will not be met; changes to mine development and completion; foreign operations risks; changes to regulation; environmental risks; the impact of weather and climate change; risks related to asset retirement obligations, general economic changes, including inflation and foreign exchange rates; the actions of the Company's competitors and counterparties; financing, liquidity, credit and capital risks; the loss of key personnel; impairment risks; cybersecurity risks; risks relating to transportation and infrastructure; changes to equipment and suppliers; concentration risks, adverse litigation; changes to permitting and licensing; geo-political risks; loss of land title and access rights; changes to insurance and uninsured risks; the potential for malicious acts; market and stock price volatility; changes to technology, innovation or artificial intelligence; changes to tax laws; the risk of operating in foreign jurisdictions; the risks posed by a controlling shareholder and other conflicts of interest; risks related to reputational damage, the risk associated with epidemics, pandemics and public health; the risks associated with environmental justice; and any risks related to internal controls over financial reporting risks. Readers are cautioned that the foregoing list of risks, uncertainties and assumptions is not exhaustive.
Although the Company has attempted to identify crucial factors that could cause actual actions, events or results to differ materially from those described in the forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Additional risks and uncertainties affecting the forward-looking information contained in this news release are described in greater detail in the Company's Annual Information Form and current Management's Discussion and Analysis available under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.itafos.com . There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. The reader is cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates, assumptions or opinions should change, except as required by applicable securities law. The forward-looking information included in this news release is expressly qualified by this cautionary statement and is made as of the date of this news release.
This news release contains future-oriented financial information and financial outlook information (together, 'FOFI') about the Company's prospective results of operations, including statements regarding expected Adjusted EBITDA, net income, basic earnings per share, corporate selling, general and administrative expenses, maintenance capex, growth capex and free cash flow. FOFI is subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraph. The Company has included the FOFI to provide an outlook of management's expectations regarding anticipated activities and results, and such information may not be appropriate for other purposes. The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's reasonable estimates and judgements; however, actual results of operations and the resulting financial results may vary from the amounts set forth herein. Any financial outlook information speaks only as of the date on which it is made and the Company undertakes no obligation to publicly update or revise any financial outlook information except as required by applicable securities laws.
NEITHER THE TSX-V NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-V) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
Contacts:
For Investor Relations:
Matthew O'Neill
Executive Vice President & Chief Financial Officer
investor@itafos.com
713-242-8446
For Media:
Alliance Advisors IR
Fatema Bhabrawala
Director, Media Relations
fbhabrawala@allianceadvisors.com
647-620-5002
Scientific and Technical Information
The scientific and technical information contained in this news release related to Mineral Resources for Conda has been reviewed and approved by Jerry DeWolfe, Professional Geologist (P.Geo.) with the Association of Professional Engineers and Geoscientists of Alberta. Mr. DeWolfe is a full-time employee of WSP Canada Inc. and is independent of the Company. The scientific and technical information contained in this news release related to Mineral Reserves for Conda has been reviewed and approved by Terry Kremmel, Professional Engineer (P.E.) licensed by the States of Missouri and North Carolina. Mr. Kremmel is a full-time employee of WSP USA, Inc. and is independent of the Company. The Company's latest technical report in respect of Conda is entitled, 'NI 43-101 Technical Report Itafos Conda Project, Idaho, USA,' with an effective date of July 1, 2023 and is available under the Company's website at www.itafos.com and under the Company's profile on SEDAR+ at www.sedarplus.ca .
Non-IFRS Financial Measures
This press release contains both IFRS and certain non-IFRS measures that management considers to evaluate the Company's operational and financial performance. Non-IFRS measures are a numerical measure of a company's performance, that either include or exclude amounts that are not normally included or excluded from the most directly comparable IFRS measures. Management believes that the non-IFRS measures provide useful supplemental information to investors, analysts, lenders and others. In evaluating non-IFRS measures, investors, analysts, lenders and others should consider that non-IFRS measures do not have any standardized meaning under IFRS and that the methodology applied by the Company in calculating such non-IFRS measures may differ among companies and analysts. Non-IFRS measures should not be considered as a substitute for, nor superior to, measures of financial performance prepared in accordance with IFRS. Definitions and reconciliations of non-IFRS measures to the most directly comparable IFRS measures are included below.
DEFINITIONS
The Company defines its non-IFRS measures as follows:
Non-IFRS measure
Definition
Most directly comparable IFRS measure
Why the Company uses the measure
EBITDA
Earnings before interest, taxes, depreciation, depletion and amortization
Net income (loss) and operating income (loss)
EBITDA is a valuable indicator of the Company's ability to generate operating income
Adjusted EBITDA
EBITDA adjusted for non-cash, extraordinary, non-recurring and other items unrelated to the Company's core operating activities
Net income (loss) and operating income (loss)
Adjusted EBITDA is a valuable indicator of the Company's ability to generate operating income from its core operating activities normalized to remove the impact of non-cash, extraordinary and non-recurring items. The Company provides guidance on Adjusted EBITDA as useful supplemental information to investors, analysts, lenders, and others
Trailing 12 months Adjusted EBITDA
Adjusted EBITDA for the current and preceding three quarters
Net income (loss) and operating income (loss) for the current and preceding three quarters
The Company uses the trailing 12 months Adjusted EBITDA in the calculation of the net leverage ratio (non-IFRS measure)
Total capex
Additions to property, plant, and equipment and mineral properties adjusted for additions to asset retirement obligations, additions to right-of-use assets and capitalized interest
Additions to property, plant and equipment and mineral properties
The Company uses total capex in the calculation of total cash capex (non-IFRS measure)
Maintenance capex
Portion of total capex relating to the maintenance of ongoing operations
Additions to property, plant and equipment and mineral properties
Maintenance capex is a valuable indicator of the Company's required capital expenditures to sustain operations at existing levels
Growth capex
Portion of total capex relating to the development of growth opportunities
Additions to property, plant and equipment and mineral properties
Growth capex is a valuable indicator of the Company's capital expenditures related to growth opportunities.
Net debt
Debt less cash and cash equivalents plus deferred financing costs (does not consider lease liabilities)
Current debt, long-term debt and cash and cash equivalents
Net debt is a valuable indicator of the Company's net debt position as it removes the impact of deferring financing costs.
Net leverage ratio
Net debt divided by trailing 12 months Adjusted EBITDA
Current debt, long-term debt and cash and cash equivalents; net income (loss) and operating income (loss) for the current and preceding three quarters
The Company's net leverage ratio is a valuable indicator of its ability to service its debt from its core operating activities.
Liquidity
Cash and cash equivalents plus undrawn committed borrowing capacity
Cash and cash equivalents
Liquidity is a valuable indicator of the Company's liquidity
Free cash flow
Cash flows from operating activities, which excludes payment of interest expense, plus cash flows from investing activities
Cash flows from operating activities and cash flows from investing activities
Free cash flow is a valuable indicator of the Company's ability to generate cash flows from operations after giving effect to required capital expenditures to sustain operations at existing levels. Free cash flow is a valuable indicator of the Company's cash flow available for debt service or to fund growth opportunities. The Company provides guidance on free cash flow as useful supplemental information to investors, analysts, lenders, and others.
Corporate selling, general and administrative expenses
Corporate selling, general and administrative less share-based payments expense.
Selling, general and administrative expenses
The Company uses corporate selling, general and administrative expenses to assess corporate performance.
EBITDA, ADJUSTED EBITDA AND TRAILING 12 MONTHS ADJUSTED EBITDA
For the three months ended March 31, 2025 and 2024
For the three months ended March 31, 2025, the Company had EBITDA and Adjusted EBITDA by segment as follows:
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Net income (loss)
$
22,718
$
1,866
$
(444
)
$
11,731
$
35,871
Finance (income) expense, net
1,077
(167
)

1,338
2,248
Current and deferred income tax expense
6,639


6,404
13,043
Depreciation and depletion
10,238
614

77
10,929
EBITDA
$
40,672
$
2,313
$
(444
)
$
19,550
$
62,091
Unrealized foreign exchange (gain) loss

(371
)
160

(211
)
Share-based payment expense



2,497
2,497
Transaction costs



92
92
Other (income) expense, net
233
42

(25,465
)
(25,190
)
Adjusted EBITDA
$
40,905
$
1,984
$
(284
)
$
(3,326
)
$
39,279
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Operating income (loss)
$
30,671
$
1,370
$
(284
)
$
(5,972
)
$
25,785
Depreciation and depletion
10,238
614

77
10,929
Realized foreign exchange loss
(4
)


(20
)
(24
)
Share-based payment expense



2,497
2,497
Transaction costs



92
92
Adjusted EBITDA
$
40,905
$
1,984
$
(284
)
$
(3,326
)
$
39,279
For the three months ended March 31, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows:
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Net income (loss)
$
29,512
$
277
$
(193
)
$
(5,879
)
$
23,717
Finance (income) expense, net
1,433
(252
)
1
2,387
3,569
Current and deferred income tax expense (recovery)
6,484


(2,330
)
4,154
Depreciation and depletion
8,926
701
5
85
9,717
EBITDA
$
46,355
$
726
$
(187
)
$
(5,737
)
41,157
Unrealized foreign exchange (gain) loss

611
(67
)

544
Share-based payment expense



422
422
Transaction costs



227
227
Non-recurring compensation expenses



1,560
1,560
Other (income) expense, net
211
(955
)
1

(743
)
Adjusted EBITDA
$
46,566
$
382
$
(253
)
$
(3,528
)
$
43,167
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Operating income (loss)
$
37,637
$
(319
)
$
(258
)
$
(5,822
)
$
31,238
Depreciation and depletion
8,926
701
5
85
9,717
Realized foreign exchange gain
3



3
Share-based payment expense



422
422
Transaction costs



227
227
Non-recurring compensation expenses



1,560
1,560
Adjusted EBITDA
$
46,566
$
382
$
(253
)
$
(3,528
)
$
43,167
As of March 31, 2025 and December 31, 2024
As of March 31, 2025, and December 31, 2024, the Company had trailing 12 months Adjusted EBITDA5 as follows:
(unaudited in thousands of US Dollars)
March 31,
2025
December 31,
2024
For the three months ended March 31, 2025
$
39,279
$

For the three months ended December 31, 2024
45,473
45,473
For the three months ended September 30, 2024
38,011
38,011
For the three months ended June 30, 2024
32,810
32,810
For the three months ended March 31, 2024

43,167
Trailing 12 months Adjusted EBITDA
$
155,573
$
159,461
________________________________
5Please refer to the press releases issued by the Company relating to the filings for the December 31, 2024, September 30, 2024 and June 30, 2024 periods for the quantitative reconciliation.
TOTAL CAPEX
For the three months ended March 31, 2025 and 2024
For the three months ended March 31, 2025, the Company had capex by segment as follows:
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Additions to property, plant and equipment
$
4,659
$
2,193
$
15
$

$
6,867
Additions to mineral properties
7,987
225
14

8,226
Additions to asset retirement obligations
(3,106
)
(370
)


(3,476
)
Additions to right-of-use assets

(260
)
(15
)

(275
)
Capitalized interest in property, plant, and equipment and mineral properties
(1,421
)



(1,421
)
Total capex
$
8,119
$
1,788
$
14
$

$
9,921
Accrued capex
(1,878
)



(1,878
)
Total cash capex
$
6,241
$
1,788
$
14
$

$
8,043
Maintenance capex
$
447
$
48
$

$

$
495
Accrued maintenance capex
(33
)



(33
)
Cash maintenance capex
$
414
$
48
$

$

$
462
Growth capex
$
7,672
$
1,740
$
14
$

$
9,426
Accrued growth capex
(1,845
)



(1,845
)
Cash growth capex
$
5,827
$
1,740
$
14
$

$
7,581
For the three months ended March 31, 2024, the Company had capex by segment as follows:
(unaudited in thousands of US Dollars)
Conda
Arraias
Development
and
exploration
Corporate
Total
Additions to property, plant and equipment
$
(1,443
)
$
1,109
$
(1
)
$

$
(335
)
Additions to mineral properties
3,762



3,762
Additions to asset retirement obligations
2,987
177


3,164
Additions to right-of-use assets

(162
)
1

(161
)
Total capex
$
5,306
$
1,124
$

$

$
6,430
Accrued capex
(2,054
)



(2,054
)
Total cash capex
$
3,252
$
1,124
$

$

$
4,376
Maintenance capex
$
419
$
408
$

$

$
827
Accrued maintenance capex
(179
)



(179
)
Cash maintenance capex
$
240
$
408
$

$

$
648
Growth capex
$
4,887
$
716
$

$

$
5,603
Accrued growth capex
(1,875
)



(1,875
)
Cash growth capex
$
3,012
$
716
$

$

$
3,728
NET DEBT AND NET LEVERAGE RATIO
As of March 31, 2025, and December 31, 2024, the Company had net debt and net leverage ratio as follows:
(unaudited in thousands of US Dollars
March 31,
December 31,
except as otherwise noted)
2025
2024
Current debt
$
11,310
$
11,163
Long-term debt
84,474
86,804
Cash and cash equivalents
(100,333
)
(74,372
)
Deferred financing costs related to the Credit Facilities
2,805
3,207
Net debt
$
(1,744
)
$
26,802
Trailing 12 months Adjusted EBITDA
$
155,573
$
159,461
Net leverage ratio
(0.0)x
0.2x
LIQUIDITY
As of March 31, 2025, and December 31, 2024, the Company had liquidity as follows:
March 31,
December 31,
(unaudited in thousands of US Dollars)
2025
2024
Cash and cash equivalents
$
100,333
$
74,372
ABL Facility undrawn borrowing capacity
80,000
80,000
Liquidity
$
180,333
$
154,372
FREE CASH FLOW
For the three months ended March 31, 2025 and 2024, the Company had free cash flow as follows:
For the three months ended March 31,
(unaudited in thousands of US Dollars)
2025
2024
Cash flows from operating activities
$
31,527
$
21,555
Cash flows used by investing activities
(194
)
(3,868
)
Free cash flow
$
31,333
$
17,687
CORPORATE SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES
For the three months ended March 31, 2025 and 2024, the Company had corporate selling, general and administrative expenses as follows:
For the three months ended March 31,
(unaudited in thousands of US Dollars)
2025
2024
Selling, general and administrative expenses
$
5,972
$
5,822
Share-based payments expense
(2,497
)
(422
)
Corporate selling, general and administrative expenses
$
3,475
$
5,400
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results
Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results

Yahoo

time19 minutes ago

  • Yahoo

Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results

Strong Case Volume, Sales and Profit Growth; Announces Full-Year 2026 Financial Guidance Fourth-Quarter Fiscal 2025 Highlights Total case volume increased 11.9% Total Independent Foodservice case volume increased 20.4% Organic Independent Foodservice case volume increased 5.9% Net sales increased 11.5% to $16.9 billion Gross profit improved 14.6% to $2.0 billion Net income decreased 21.0% to $131.5 million Adjusted EBITDA increased 19.9% to $546.9 million1 Diluted Earnings Per Share ("EPS") decreased 21.5% to $0.84 Adjusted Diluted EPS increased 6.9% to $1.551 Full-Year Fiscal 2025 Highlights Total case volume increased 8.5% Total Independent Foodservice case volume increased 16.9% Organic Independent Foodservice case volume increased 4.6% Net sales increased 8.6% to $63.3 billion Gross profit improved 12.8% to $7.4 billion Net income decreased 22.0% to $340.2 million Adjusted EBITDA increased 17.3% to $1.8 billion1 Diluted EPS decreased 21.9% to $2.18 Adjusted Diluted EPS increased 4.2% to $4.481 Operating Cash Flow of $1.2 billion Free cash flow of $704.1 million1 RICHMOND, Va., August 13, 2025--(BUSINESS WIRE)--Performance Food Group Company ("PFG" or the "Company") (NYSE: PFGC) today announced its fourth-quarter and full-year fiscal 2025 business results. "Our organization finished fiscal 2025 with strong financial results driven by contributions from each of our three operating segments," said George Holm, PFG's Chairman & Chief Executive Officer. "I am proud of the accomplishments of our 43,000 employees, particularly our sales associates, who continue to drive share gains across our business segments. We enter fiscal 2026 with a stable industry backdrop and significant business momentum and we are on track to achieve the 3-year financial targets we announced in May. The PFG team continues to execute our strategic plan, headlined by growth, market share gains and operational execution, leading to enhanced profitability. As we progress with the integration of Cheney Brothers and José Santiago, we believe the Company will continue to create enhanced shareholder value. We are confident in our ability to achieve the fiscal 2026 targets that we announced today." 1 This earnings release includes several metrics, including Adjusted EBITDA, Adjusted Diluted Earnings Per Share, and Free Cash Flow, that are not calculated in accordance with Generally Accepted Accounting Principles in the U.S. ("GAAP"). Please see "Statement Regarding Non-GAAP Financial Measures" at the end of this release for the definitions of such non-GAAP financial measures and reconciliations of such non-GAAP financial measures to their respective most comparable financial measures calculated in accordance with GAAP. Fourth-Quarter Fiscal 2025 Financial Summary Total case volume increased 11.9% for the fourth quarter of fiscal 2025 compared to the prior year period. Total organic case volume increased 3.9% for the fourth quarter of fiscal 2025 compared to the prior year period, benefiting from a 5.9% increase in organic independent cases and growth in cases sold to Foodservice's chain business. Total independent case volume increased 20.4%. Net sales for the fourth quarter of fiscal 2025 grew 11.5% to $16.9 billion compared to the prior year period. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Bros., Inc. ("Cheney Brothers"), an increase in cases sold including a favorable shift in the mix of cases sold, and an increase in selling price per case as a result of inflation. Overall product cost inflation for the Company was approximately 4.3% for the fourth quarter of fiscal 2025. Gross profit for the fourth quarter of fiscal 2025 grew 14.6% to $2.0 billion compared to the prior year period. The gross profit increase was driven by recent acquisitions as well as cost of goods sold optimization through procurement efficiencies, partially offset by an increase in the last-in-first-out ("LIFO") inventory reserve. Operating expenses rose 18.3% to $1.7 billion in the fourth quarter of fiscal 2025 compared to the prior year period. The increase in operating expenses was primarily driven by recent acquisitions, an increase in personnel expense primarily related to wages and salaries, commissions, and benefits, an increase in depreciation expense mainly driven by an increase in transportation equipment under finance leases, an increase in insurance expense primarily related to workers' compensation and vehicle liability, and an increase in professional fees primarily related to recent acquisitions, partially offset by a decrease in fuel expense primarily due to lower fuel prices in the fourth quarter of fiscal 2025 as compared to the prior fiscal year period. Net income for the fourth quarter of fiscal 2025 decreased $35.0 million year-over-year to $131.5 million. The decrease was primarily a result of an increase in depreciation and amortization and interest expense primarily related to recent acquisitions, partially offset by a decrease in income tax expense and gross profit contributions from recent acquisitions. The effective tax rate in the fourth quarter of fiscal 2025 was approximately 25.6% compared to 26.0% in the fourth quarter of fiscal 2024. The effective tax rate for the fourth quarter of fiscal 2025 differed from the prior year period primarily due to an increased benefit from stock-based compensation and an increase in income tax credits net of valuation allowance established, partially offset by an increase in non-deductible expenses. For the quarter, Adjusted EBITDA rose 19.9% to $546.9 million compared to the prior year period. Diluted EPS decreased 21.5% to $0.84 per share in the fourth quarter of fiscal 2025 compared to the prior year period. Adjusted Diluted EPS increased 6.9% to $1.55 per share in the fourth quarter of fiscal 2025 compared to the prior year period. Full-Year Fiscal 2025 Financial Summary Total case volume increased 8.5% for fiscal 2025 compared to the prior fiscal year. Total organic case volume increased 2.1% for fiscal 2025 compared to the prior year period, benefiting from a 4.6% increase in organic independent cases sold during fiscal 2025 and growth in cases sold to Foodservice's chain business. Total independent case volume increased 16.9%. Net sales for fiscal 2025 grew 8.6% to $63.3 billion compared to the prior fiscal year. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Brothers, an increase in cases sold including a favorable shift in mix of cases sold, and an increase in selling price per case as a result of inflation. Overall product cost inflation for the Company was approximately 4.7% for fiscal 2025. Gross profit for fiscal 2025 grew 12.8% to $7.4 billion compared to the prior fiscal year. The increase in gross profit was primarily driven by recent acquisitions, including the acquisition of Cheney Brothers, cost of goods sold optimization through procurement efficiencies, as well as a favorable shift in the mix of cases sold, including growth in the independent channel. Operating expenses rose 14.8% to $6.6 billion in fiscal 2025 compared to the prior fiscal year. The increase in operating expenses was primarily driven by recent acquisitions, including the acquisition of Cheney Brothers, increases in personnel expenses primarily related to wages and salaries, commissions, and benefits, an increase in depreciation expense mainly driven by an increase in transportation equipment under finance leases, an increase in professional fees and outside services primarily related to recent acquisitions, and an increase in insurance expense primarily related to workers' compensation and vehicle liability compared to prior year. These increases were partially offset by a decrease in fuel expense primarily due to lower fuel prices for fiscal 2025 as compared to the prior fiscal year. Net income for fiscal 2025 decreased $95.7 million year-over-year to $340.2 million driven by an increase in depreciation and amortization and interest expense primarily related to recent acquisitions, partially offset by a decrease in income tax expense and gross profit contributions from recent acquisitions. The increase in interest expense was primarily the result of an increase in average borrowings, including finance lease obligations, during fiscal 2025 compared to the prior fiscal year. The effective tax rate in fiscal 2025 was approximately 25.8% compared to 27.0% in fiscal 2024. The effective tax rate for fiscal 2025 differed from the prior fiscal year primarily due to an increased benefit from stock-based compensation and an increase in income tax credits net of valuation allowance established, partially offset by an increase in non-deductible expenses and an increase in state taxes as a percentage of income. For fiscal 2025, Adjusted EBITDA rose 17.3% to $1.8 billion compared to the prior year period. Diluted EPS decreased 21.9% to $2.18 per share in fiscal 2025 compared to the prior year period. Adjusted Diluted EPS increased 4.2% to $4.48 per share in fiscal 2025 compared to the prior year period. Cash Flow and Capital Spending In fiscal 2025, PFG provided $1,210.1 million in cash flow from operating activities compared to $1,163.0 million in cash flow from operating activities in the prior year period. The increase in cash flows provided by operating activities in fiscal 2025 compared to fiscal 2024 was largely driven by higher cash-based operating income, partially offset by changes in the timing of advanced purchases of inventory. In fiscal 2025, PFG invested $506.0 million in capital expenditures, an increase of $110.4 million versus the prior year period. In fiscal 2025, PFG delivered free cash flow of $704.1 million compared to free cash flow of $767.4 million in the prior year period.1 Share Repurchase Program In November 2022, the Board of Directors of the Company authorized a share repurchase program for up to $300 million of the Company's outstanding common stock. During the three months ended June 28, 2025, the Company repurchased and subsequently retired 0.2 million shares of common stock, for a total of $13.4 million or an average cost of $75.39 per share. During the fiscal year ended June 28, 2025, the Company repurchased and subsequently retired 0.8 million shares of common stock, for a total of $57.6 million or an average cost of $75.53 per share. On May 27, 2025, the Board of Directors authorized a new share repurchase program for up to $500 million of the Company's outstanding common stock. This authorization replaces the previously authorized $300 million share repurchase program. The new share repurchase program has an expiration date of May 27, 2029 and may be amended, suspended, or discontinued at any time at the Board of Directors' discretion, subject to compliance with applicable laws. As of June 28, 2025, there remains $500 million available for additional share repurchases. Fourth-Quarter Fiscal 2025 Segment Results Foodservice Fourth-quarter fiscal 2025 net sales for Foodservice increased 20.0% to $9.2 billion compared to the prior year period. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Brothers, case volume growth, including growth in our independent and Chain business, and an increase in selling price per case as a result of inflation. Total case growth for Foodservice was 17.4% in the fourth quarter of fiscal 2025 compared to the prior year period. New account growth and increased penetration coupled with recent acquisitions resulted in total independent case growth of 20.4% for the fourth quarter of fiscal 2025 compared to the prior year period. Organic independent case growth was 5.9% in the fourth quarter of fiscal 2025 compared to the prior year period. For the fourth quarter of fiscal 2025, independent sales as a percentage of total Foodservice sales were 41.3%. Fourth-quarter fiscal 2025 Adjusted EBITDA for Foodservice increased 26.3% to $386.9 million compared to the prior year period. The increase was the result of an increase in gross profit, partially offset by an increase in operating expenses for the fourth quarter of fiscal 2025 compared to the prior year period. Gross profit contributing to Foodservice's Adjusted EBITDA increased 24.9% driven by recent acquisitions, growth in cases sold, including more Performance Brands products sold to our independent customers, and a favorable shift in the mix of cases sold. Operating expenses impacting Foodservice's Adjusted EBITDA increased 24.4% primarily as a result of recent acquisitions, and an increase in personnel expenses compared to the prior year period. Convenience Fourth-quarter fiscal 2025 net sales for Convenience increased 2.8% to $6.4 billion compared to the prior year period. The increase in net sales for Convenience was driven by higher selling prices per case due to continued inflation, an acquisition completed in the fourth quarter of fiscal 2025, and organic case volume growth of 0.6% in the fourth quarter compared to the prior year period. Fourth-quarter fiscal 2025 Adjusted EBITDA for Convenience increased 4.8% to $120.0 million compared to the prior year period. This increase was a result of an increase in gross profit, partially offset by an increase in operating expenses. Gross profit contributing to Convenience's Adjusted EBITDA increased 3.4% for the fourth quarter of fiscal 2025 compared to the prior year period primarily driven by inventory holding gains, an acquisition completed in the fourth quarter of fiscal 2025, and a favorable shift in the mix of cases sold, partially offset by prior year releases of aged accruals. Operating expenses impacting Convenience's Adjusted EBITDA increased 2.4% in the fourth quarter of fiscal 2025 compared to the prior year period primarily as a result of an increase in personnel expenses and an acquisition completed in the fourth quarter of fiscal 2025, partially offset by a decrease in fuel expense primarily due to lower fuel prices compared to the prior year period. Specialty For the fourth quarter of fiscal 2025, net sales for Specialty increased 4.1% to $1.3 billion compared to the prior year period. This increase was primarily driven by growth in the vending, office coffee, value, and retail channels in the fourth quarter of fiscal 2025 compared to the prior year period. Total case volume growth for Specialty for the fourth quarter of fiscal 2025 was 4.2% compared to the prior year period. Fourth-quarter fiscal 2025 Adjusted EBITDA for Specialty increased 9.0% to $93.2 million compared to the prior year period. This increase was a result of an increase in gross profit, slightly offset by an increase in operating expenses. The 3.7% increase in gross profit contributing to Specialty's Adjusted EBITDA was primarily driven by sales growth and inventory holding gains, and a favorable shift in the mix of cases sold. Operating expenses impacting Specialty's Adjusted EBITDA increased 0.3% primarily due to an increase in variable expense growth in small parcel fulfillment, partially offset by a reduction in lease expense as the segment has transitioned to finance leases for fleet equipment, a decrease in fuel expense, and recovery of bad debt in the fourth quarter of fiscal 2025 compared to the prior year period. Fiscal 2026 Outlook For the first quarter of fiscal 2026, PFG expects net sales to be in a range of approximately $16.6 billion to $16.9 billion. For the first quarter of fiscal 2026, PFG expects Adjusted EBITDA to be in a range of approximately $465 million to $485 million. For the full fiscal year 2026, PFG expects net sales to be in a range of approximately $67 billion to $68 billion. For the full fiscal year 2026, PFG expects Adjusted EBITDA to be in a range of approximately $1.9 billion to $2.0 billion. PFG's Adjusted EBITDA outlook excludes the impact of certain income and expense items that management believes are not part of underlying operations. These items may include, but are not limited to, losses on early extinguishments of debt, restructuring charges, certain tax items, and charges associated with non-recurring professional and legal fees associated with acquisitions. PFG's management cannot estimate on a forward-looking basis the impact of these income and expense items on its reported net income, which could be significant, are difficult to predict, and may be highly variable. As a result, PFG does not provide a reconciliation to the closest corresponding GAAP financial measure for its Adjusted EBITDA outlook. Please see the "Forward-Looking Statements" section of this release for a discussion of certain risks to PFG's outlook. Conference Call As previously announced, a conference call with the investment community and news media will be webcast today, August 13, 2025, at 9:00 a.m. Eastern Time. Access to the webcast is available at About Performance Food Group Company Performance Food Group is an industry leader and one of the largest food and foodservice distribution companies in North America with more than 150 locations. Founded and headquartered in Richmond, Virginia, PFG and our family of companies market and deliver quality food and related products to over 300,000 locations including independent and chain restaurants; businesses, schools and healthcare facilities; vending and office coffee service distributors; and big box retailers, theaters and convenience stores. PFG's success as a Fortune 100 company is achieved through our approximately 43,000 dedicated associates committed to building strong relationships with the valued customers, suppliers and communities we serve. To learn more about PFG, visit Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements related to our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, and integration of our acquisition of Cheney Bros., Inc. (the "Cheney Brothers Acquisition") and other nonhistorical statements. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "could," "seeks," "projects," "predicts," "intends," "plans," "estimates," "anticipates" or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. The following factors, in addition to those discussed under the section entitled Item 1A. Risk Factors in PFG's Annual Report on Form 10-K for the fiscal year ended June 29, 2024 filed with the Securities and Exchange Commission (the "SEC") on August 14, 2024, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC's website at could cause actual future results to differ materially from those expressed in any forward-looking statements: costs and risks associated with a potential cybersecurity incident or other technology disruption; our reliance on technology and risks associated with disruption or delay in implementation of new technology, including artificial intelligence; economic factors, including inflation or other adverse changes such as a downturn in economic conditions, geopolitical events, tariff increases, or a public health crisis, negatively affecting consumer confidence and discretionary spending; our reliance on third-party suppliers; labor relations and cost risks and availability of qualified labor; competition in our industry is intense, and we may not be able to compete successfully; we operate in a low margin industry, which could increase the volatility of our results of operations; we may not realize anticipated benefits from our operating cost reduction and productivity improvement efforts; our profitability is directly affected by cost inflation and deflation, commodity volatility, and other factors; we do not have long-term contracts with certain customers; group purchasing organizations may become more active in our industry and increase their efforts to add our customers as members of these organizations; changes in eating habits of consumers; extreme weather conditions, including hurricane, earthquake and natural disaster damage and extreme heat or cold; volatility of fuel and other transportation costs; our inability to adjust cost structure where one or more of our competitors successfully implement lower costs; our inability to increase our sales in the highest margin portion of our business; changes in pricing practices of our suppliers; our growth and innovation strategy may not achieve the anticipated results; risks relating to acquisitions, including the risk that we are not able to realize benefits of acquisitions or successfully integrate the businesses we acquire or that we incur significant integration costs; a portion of our sales volume is dependent upon the distribution of cigarettes and other tobacco products, sales of which are generally declining; negative media exposure and other events that damage our reputation; impact of uncollectibility of accounts receivable; the cost and adequacy of insurance coverage and increases in the number or severity of insurance and claims expenses; the potential impacts of shareholder activists or potential bidders; the integration of artificial intelligence into our processes; environmental, health, and safety costs, including compliance with current and future environmental laws and regulations relating to carbon emissions and climate change and related legal or market measures; our inability to comply with requirements imposed by applicable law or government regulations, including increased regulation of e-vapor products and other alternative nicotine products; increase in excise taxes or reduction in credit terms by taxing jurisdictions; the potential impact of product recalls and product liability claims relating to the products we distribute and other litigation; adverse judgments or settlements or unexpected outcomes in legal proceedings; risks relating to our outstanding indebtedness, including the impact of interest rate increases on our variable rate debt; our ability to raise additional capital on commercially reasonable terms or at all; and the possibility that the expected synergies and other benefits from the Cheney Brothers Acquisition will not be realized or will not be realized within the expected time period. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC. Any forward-looking statement, including any contained herein, speaks only as of the time of this release or as of the date they were made and we do not undertake to update or revise them as more information becomes available or to disclose any facts, events, or circumstances after the date of this release or our statement, as applicable, that may affect the accuracy of any forward-looking statement, except as required by law. PERFORMANCE FOOD GROUP COMPANY CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In millions, except per share data) Three Months EndedJune 28, 2025 Three Months EndedJune 29, 2024 Fiscal Year EndedJune 28, 2025 Fiscal Year EndedJune 29, 2024 Net sales $ 16,938.9 $ 15,189.2 $ 63,298.9 $ 58,281.2 Cost of goods sold 14,936.7 13,442.0 55,882.3 51,704.1 Gross profit 2,002.2 1,747.2 7,416.6 6,577.1 Operating expenses 1,734.4 1,465.8 6,600.3 5,750.7 Operating profit 267.8 281.4 816.3 826.4 Other expense, net: Interest expense, net 94.5 57.6 358.4 232.2 Other, net (3.4 ) (1.2 ) (0.9 ) (2.6 ) Other expense, net 91.1 56.4 357.5 229.6 Income before taxes 176.7 225.0 458.8 596.8 Income tax expense 45.2 58.5 118.6 160.9 Net income $ 131.5 $ 166.5 $ 340.2 $ 435.9 Weighted-average common shares outstanding: Basic 155.0 154.3 154.8 154.4 Diluted 156.6 156.0 156.4 156.0 Earnings per common share: Basic $ 0.85 $ 1.08 $ 2.20 $ 2.82 Diluted $ 0.84 $ 1.07 $ 2.18 $ 2.79 PERFORMANCE FOOD GROUP COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In millions) As ofJune 28, 2025 As ofJune 29, 2024 ASSETS Current assets: Cash $ 78.5 $ 20.0 Accounts receivable, less allowances of $69.0 and $55.2 2,833.0 2,478.9 Inventories, net 3,887.7 3,314.7 Income taxes receivable 96.2 71.6 Prepaid expenses and other current assets 239.7 268.1 Total current assets 7,135.1 6,153.3 Goodwill 3,480.1 2,418.3 Other intangible assets, net 1,688.5 971.1 Property, plant and equipment, net 4,458.7 2,788.5 Operating lease right-of-use assets 933.8 875.5 Other assets 185.0 186.2 Total assets $ 17,881.2 $ 13,392.9 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Trade accounts payable and outstanding checks in excess of deposits $ 3,165.3 $ 2,594.4 Accrued expenses and other current liabilities 1,025.9 908.3 Finance lease obligations—current installments 221.9 147.2 Operating lease obligations—current installments 104.5 108.2 Total current liabilities 4,517.6 3,758.1 Long-term debt 5,388.8 3,198.5 Deferred income tax liability, net 887.1 497.9 Finance lease obligations, excluding current installments 1,379.9 703.2 Operating lease obligations, excluding current installments 900.7 819.3 Other long-term liabilities 334.7 289.0 Total liabilities 13,408.8 9,266.0 Total shareholders' equity 4,472.4 4,126.9 Total liabilities and shareholders' equity $ 17,881.2 $ 13,392.9 PERFORMANCE FOOD GROUP COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) Fiscal Year EndedJune 28, 2025 Fiscal Year EndedJune 29, 2024 Cash flows from operating activities: Net income $ 340.2 $ 435.9 Adjustments to reconcile net income to net cash provided by operating activities Depreciation and intangible asset amortization 717.9 556.7 Provision for losses on accounts receivables 22.7 19.8 Change in LIFO Reserve 88.1 62.3 Other non-cash activities 61.9 57.5 Changes in operating assets and liabilities, net: Accounts receivable (151.9 ) (81.1 ) Inventories (337.9 ) 37.7 Income taxes receivable (17.5 ) (29.9 ) Prepaid expenses and other assets 56.6 (95.8 ) Trade accounts payable and outstanding checks in excess of deposits 372.7 124.0 Accrued expenses and other liabilities 57.3 75.9 Net cash provided by operating activities 1,210.1 1,163.0 Cash flows from investing activities: Purchases of property, plant and equipment (506.0 ) (395.6 ) Net cash paid for acquisitions (2,596.4 ) (307.7 ) Proceeds from sale of property, plant and equipment and other 13.4 20.6 Net cash used in investing activities (3,089.0 ) (682.7 ) Cash flows from financing activities: Net borrowings under ABL Facility 1,194.2 6.8 Repayment of Notes due 2025 (275.0 ) Borrowing of Notes due 2032 1,000.0 — Cash paid for debt issuance, extinguishment and modifications (34.2 ) — Payments under finance lease obligations (188.0 ) (122.2 ) Net cash paid for acquisitions (1.5 ) — Proceeds from exercise of stock options and employee stock purchase plan 43.8 17.7 Cash paid for shares withheld to cover taxes (18.8 ) (21.5 ) Repurchases of common stock (57.6 ) (78.1 ) Other financing activities — (0.3 ) Net cash provided by (used in) financing activities 1,937.9 (472.6 ) Net increase in cash and restricted cash 59.0 7.7 Cash and restricted cash, beginning of period 27.7 20.0 Cash and restricted cash, end of period $ 86.7 $ 27.7 The following table provides a reconciliation of cash and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows: (In millions) As ofJune 28, 2025 As ofJune 29, 2024 Cash $ 78.5 $ 20.0 Restricted cash(1) 8.2 7.7 Total cash and restricted cash $ 86.7 $ 27.7 (1) Restricted cash is reported within other assets and represents the amounts required by insurers to collateralize a part of the deductibles for the Company's workers' compensation and liability claims. Supplemental disclosures of cash flow information are as follows: (In millions) Fiscal Year EndedJune 28, 2025 Fiscal Year EndedJune 29, 2024 Cash paid during the year for: Interest net of amounts capitalized $ 344.4 $ 242.1 Income tax payments net of refunds 129.7 177.1 Statement Regarding Non-GAAP Financial Measures This earnings release and the accompanying financial statement tables include several financial measures that are not calculated in accordance with GAAP, including Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow. Such measures are not recognized terms under GAAP, should not be considered in isolation or as a substitute for measures prepared in accordance with GAAP, and are not indicative of net income as determined under GAAP. Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow, and other non-GAAP financial measures have limitations that should be considered before using these measures to evaluate PFG's liquidity or financial performance. Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow, as presented, may not be comparable to similarly titled measures of other companies because of varying methods of calculation. PFG uses Adjusted EBITDA to evaluate the performance of its business on a consistent basis over time and for business planning purposes. In addition, targets based on Adjusted EBITDA are among the measures we use to evaluate our management's performance for purposes of determining their compensation under our incentive plans. PFG believes that the presentation of Adjusted EBITDA enhances an investor's understanding of PFG's performance. PFG believes this measure is a useful metric to assess PFG's operating performance from period to period by excluding certain items that PFG believes are not representative of PFG's core business. Management measures operating performance based on our Adjusted EBITDA, defined as net income before interest expense, interest income, income and franchise taxes, and depreciation and amortization, further adjusted to exclude certain items we do not consider part of our core operating results. Such adjustments include certain unusual, non-cash, non-recurring, cost reduction and other adjustment items outside of the ordinary course of the Company's operations and not indicative of ongoing performance as permitted in calculating covenant compliance under PFG's $5.0 billion secured credit facility (the "ABL Facility") and indentures governing its outstanding notes (other than certain pro forma adjustments permitted under our ABL Facility and indentures relating to the Adjusted EBITDA contribution of acquired entities or businesses prior to the acquisition date). Under our ABL Facility and indentures, PFG's ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and making restricted payments is tied to ratios based on Adjusted EBITDA (as defined in the ABL Facility and indentures). Management also uses Adjusted Diluted EPS, which is calculated by adjusting the most directly comparable GAAP financial measure by excluding the same items excluded in PFG's calculation of Adjusted EBITDA, as well as amortization of intangible assets, to the extent that each such item was included in the applicable GAAP financial measure. For business combinations, the Company generally allocates a portion of the purchase price to intangible assets and such intangible assets contribute to revenue generation. The amount of the allocation is based on estimates and assumptions made by management and is subject to amortization over the useful lives of the intangible assets. The amount of the purchase price from an acquisition allocated to intangible assets and the term of its related amortization can vary significantly and are unique to each acquisition, and thus the Company does not believe it is reflective of ongoing operations. Intangible asset amortization excluded from Adjusted Diluted EPS represents the entire amount recorded within the Company's GAAP financial statements; whereas, the revenue generated by the associated intangible assets has not been excluded from Adjusted Diluted EPS. Intangible asset amortization is excluded from Adjusted Diluted EPS because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired, or the estimated useful life of an intangible asset is revised. Management also uses Free Cash Flow, which is defined as net cash provided by operating activities less capital expenditures (purchases of property, plant, and equipment). PFG also believes that the presentation of Free Cash Flow enhances an investor's understanding of PFG's ability to make strategic investments and manage debt levels. PFG believes that the presentation of Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow is useful to investors because these metrics provide insight into underlying business trends and year-over-year results and are frequently used by securities analysts, investors, and other interested parties in their evaluation of the operating performance of companies in PFG's industry. The following tables include a reconciliation of non-GAAP financial measures to the applicable most comparable GAAP financial measures. PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Three Months Ended (In millions, except per share data) June 28, 2025 June 29, 2024 Change % Net income (GAAP) $ 131.5 $ 166.5 $ (35.0 ) (21.0 ) Interest expense, net 94.5 57.6 36.9 64.1 Income tax expense 45.2 58.5 (13.3 ) (22.7 ) Depreciation 126.2 94.4 31.8 33.7 Amortization of intangible assets 69.4 50.4 19.0 37.7 Change in LIFO reserve (A) 49.2 11.8 37.4 316.9 Stock-based compensation expense 12.2 10.2 2.0 19.6 (Gain) loss on fuel derivatives (0.2 ) 0.5 (0.7 ) (140.0 ) Acquisition, integration & reorganization expenses (B) 11.6 4.6 7.0 152.2 Other adjustments (C) 7.3 1.7 5.6 329.4 Adjusted EBITDA (Non-GAAP) $ 546.9 $ 456.2 $ 90.7 19.9 Diluted earnings per share (GAAP) $ 0.84 $ 1.07 $ (0.23 ) (21.5 ) Impact of amortization of intangible assets 0.44 0.32 0.12 37.5 Impact of change in LIFO reserve 0.31 0.08 0.23 287.5 Impact of stock-based compensation expense 0.08 0.07 0.01 14.3 Impact of (gain) loss on fuel derivatives — — — — Impact of acquisition, integration & reorganization charges 0.07 0.03 0.04 133.3 Impact of other adjustment items 0.05 0.01 0.04 400.0 Tax impact of above adjustments (0.24 ) (0.13 ) (0.11 ) (84.6 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.55 $ 1.45 $ 0.10 6.9 A. Includes increases in the LIFO inventory reserve of $5.6 million for Foodservice and $43.6 million for Convenience for the fourth quarter of fiscal 2025 compared to an increase of $4.4 million for Foodservice and an increase of $7.4 million for Convenience for the fourth quarter of fiscal 2024. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of fixed assets, and other adjustments permitted by our ABL Facility. PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended (In millions, except per share data) June 28, 2025 June 29, 2024 Change % Net income (GAAP) $ 340.2 $ 435.9 $ (95.7 ) (22.0 ) Interest expense, net 358.4 232.2 126.2 54.3 Income tax expense 118.6 160.9 (42.3 ) (26.3 ) Depreciation 455.3 355.2 100.1 28.2 Amortization of intangible assets 262.6 201.5 61.1 30.3 Change in LIFO reserve (A) 88.1 62.3 25.8 41.4 Stock-based compensation expense 47.8 41.9 5.9 14.1 Loss (gain) on fuel derivatives 0.2 (1.8 ) 2.0 111.1 Acquisition, integration & reorganization expenses (B) 87.8 23.7 64.1 270.5 Other adjustments (C) 7.9 (5.7 ) 13.6 238.6 Adjusted EBITDA (Non-GAAP) $ 1,766.9 $ 1,506.1 $ 260.8 17.3 Diluted earnings per share (GAAP) $ 2.18 $ 2.79 $ (0.61 ) (21.9 ) Impact of amortization of intangible assets 1.68 1.29 0.39 30.2 Impact of change in LIFO reserve 0.56 0.40 0.16 40.0 Impact of stock-based compensation 0.31 0.27 0.04 14.8 Impact of loss (gain) on fuel derivatives — (0.01 ) 0.01 100.0 Impact of acquisition, integration & reorganization charges 0.56 0.15 0.41 273.3 Impact of other adjustment items 0.05 (0.03 ) 0.08 266.7 Tax impact of above adjustments (0.86 ) (0.56 ) (0.30 ) (53.6 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 4.48 $ 4.30 $ 0.18 4.2 A. Includes increases in the LIFO inventory reserve of $6.6 million for Foodservice and $81.5 million for Convenience for fiscal 2025 compared to increases of $3.8 million for Foodservice and $58.5 million for Convenience for fiscal 2024. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes a $3.8 million gain on the sale of a Foodservice warehouse facility for fiscal year 2025 and an $8.1 million gain on the sale of a Foodservice warehouse facility for fiscal year 2024, as well as amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of other fixed assets, and other adjustments permitted by our ABL Facility. (In millions) Fiscal Year EndedJune 28, 2025 Fiscal Year EndedJune 29, 2024 Net cash provided by operating activities (GAAP) $ 1,210.1 $ 1,163.0 Purchases of property, plant and equipment (506.0 ) (395.6 ) Free cash flow (Non-GAAP) $ 704.1 $ 767.4 PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended June 28, 2025 (In millions, except per share data) Q1 Q2 Q3 Q4 Net income (GAAP) $ 108.0 $ 42.4 $ 58.3 $ 131.5 Interest expense, net 66.8 100.2 96.9 94.5 Income tax expense 38.9 14.3 20.2 45.2 Depreciation 97.4 114.1 117.6 126.2 Amortization of intangible assets 55.5 68.4 69.3 69.4 Change in LIFO reserve (A) 12.7 17.8 8.4 49.2 Stock-based compensation expense 11.3 11.7 12.6 12.2 Loss (gain) on fuel derivatives 1.4 (0.8 ) (0.2 ) (0.2 ) Acquisition, integration & reorganization expenses (B) 19.1 51.3 5.8 11.6 Other adjustments (C) 0.8 3.6 (3.8 ) 7.3 Adjusted EBITDA (Non-GAAP) $ 411.9 $ 423.0 $ 385.1 $ 546.9 Diluted earnings per share (GAAP) $ 0.69 $ 0.27 $ 0.37 $ 0.84 Impact of amortization of intangible assets 0.36 0.44 0.44 0.44 Impact of change in LIFO reserve 0.08 0.11 0.05 0.31 Impact of stock-based compensation 0.07 0.08 0.08 0.08 Impact of loss (gain) on fuel derivatives 0.01 — — — Impact of acquisition, integration & reorganization charges 0.12 0.33 0.04 0.07 Impact of other adjustment items 0.01 0.02 (0.02 ) 0.05 Tax impact of above adjustments (0.18 ) (0.27 ) (0.17 ) (0.24 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.16 $ 0.98 $ 0.79 $ 1.55 A. Includes increases (decreases) in the LIFO inventory reserve of $0.9 million, ($0.1) million, $0.2 million, and $5.6 million for Foodservice and $11.8 million, $17.9 million, $8.2 million, and $43.6 million for Convenience for the first quarter, second quarter, third quarter, and fourth quarter of fiscal 2025, respectively. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes an $3.8 million gain on the sale of a Foodservice warehouse facility in the third quarter of fiscal 2025, as well as amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of other fixed assets, and other adjustments permitted by our ABL Facility. PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended June 29, 2024 (In millions, except per share data) Q1 Q2 Q3 Q4 Net income (GAAP) $ 120.7 $ 78.3 $ 70.4 $ 166.5 Interest expense, net 56.1 61.4 57.1 57.6 Income tax expense 42.6 33.4 26.4 58.5 Depreciation 83.8 86.3 90.7 94.4 Amortization of intangible assets 45.5 57.0 48.6 50.4 Change in LIFO reserve (A) 19.2 21.8 9.5 11.8 Stock-based compensation expense 10.7 11.0 10.0 10.2 (Gain) loss on fuel derivatives (3.5 ) 1.8 (0.6 ) 0.5 Acquisition, integration & reorganization expenses (B) 9.8 3.9 5.4 4.6 Other adjustments (C) (1.1 ) (9.5 ) 3.2 1.7 Adjusted EBITDA (Non-GAAP) $ 383.8 $ 345.4 $ 320.7 $ 456.2 Diluted earnings per share (GAAP) $ 0.77 $ 0.50 $ 0.45 $ 1.07 Impact of amortization of intangible assets 0.29 0.36 0.31 0.32 Impact of change in LIFO reserve 0.12 0.14 0.06 0.08 Impact of stock-based compensation 0.07 0.07 0.06 0.07 Impact of (gain) loss on fuel derivatives (0.02 ) 0.01 — — Impact of acquisition, integration & reorganization charges 0.06 0.03 0.04 0.03 Impact of other adjustment items — (0.06 ) 0.02 0.01 Tax impact of above adjustments (0.14 ) (0.15 ) (0.14 ) (0.13 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.15 $ 0.90 $ 0.80 $ 1.45 A. Includes increases (decreases) in the LIFO inventory reserve of $1.7 million, ($1.1) million, ($1.2) million, and $4.4 million for Foodservice and $17.5 million, $22.9 million, $10.7 million, and $7.4 million for Convenience for the first quarter, second quarter, third quarter, and fourth quarter of fiscal 2024, respectively. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes an $8.1 million gain on the sale of a Foodservice warehouse facility in second quarter of fiscal 2024, as well as asset impairments, insurance proceeds due to hurricane and other weather related events, amounts related to favorable and unfavorable leases, foreign currency transaction gains and losses, franchise tax expense, and other adjustments permitted by our ABL Facility. Segment Results In the third quarter of fiscal 2025, the Company updated its operating segments to reflect the manner in which the business is managed. The Company continues to have three reportable segments: Foodservice, Convenience, and Specialty (formerly Vistar). Management evaluates the performance of these segments based on various operating and financial metrics, including their respective sales growth and Segment Adjusted EBITDA, which is the Company's GAAP measure of segment profit. Segment Adjusted EBITDA is defined as net income before interest expense, interest income, income taxes, depreciation, and amortization and excludes certain items that the Company does not consider part of its segments' core operating results, including stock-based compensation expense, changes in the LIFO reserve, acquisition, integration and reorganization expenses, and gains and losses related to fuel derivatives. Corporate & All Other is comprised of corporate overhead and certain operations that are not considered separate reportable segments based on their size. The presentation and amounts for the three months and fiscal year ended June 29, 2024 have been recast to reflect the updated segments. The following tables set forth net sales and Segment Adjusted EBITDA by segment and the reconciling items for Corporate & All Other and eliminations for the periods indicated (dollars in millions): Net Sales Three Months Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 9,191.5 $ 7,661.1 $ 1,530.4 20.0 Convenience 6,436.3 6,258.5 177.8 2.8 Specialty 1,253.5 1,203.7 49.8 4.1 Total Segments $ 16,881.3 $ 15,123.3 $ 1,758.0 11.6 Corporate & All Other 256.9 238.1 18.8 7.9 Intersegment Eliminations (199.3 ) (172.2 ) (27.1 ) (15.7 ) Total net sales $ 16,938.9 $ 15,189.2 $ 1,749.7 11.5 Fiscal Year Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 33,646.1 $ 29,061.5 $ 4,584.6 15.8 Convenience 24,507.5 24,177.0 330.5 1.4 Specialty 4,905.0 4,789.8 115.2 2.4 Total Segments $ 63,058.6 $ 58,028.3 $ 5,030.3 8.7 Corporate & All Other 955.0 909.2 45.8 5.0 Intersegment Eliminations (714.7 ) (656.3 ) (58.4 ) (8.9 ) Total net sales $ 63,298.9 $ 58,281.2 $ 5,017.7 8.6 Segment Adjusted EBITDA Three Months Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 386.9 $ 306.3 $ 80.6 26.3 Convenience 120.0 114.5 5.5 4.8 Specialty 93.2 85.5 7.7 9.0 Total Segments $ 600.1 $ 506.3 $ 93.8 18.5 Corporate & All Other (53.2 ) (50.1 ) (3.1 ) (6.2 ) Total Adjusted EBITDA $ 546.9 $ 456.2 $ 90.7 19.9 Fiscal Year Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 1,221.6 $ 982.2 $ 239.4 24.4 Convenience 407.3 363.6 43.7 12.0 Specialty 348.2 340.6 7.6 2.2 Total Segments $ 1,977.1 $ 1,686.4 $ 290.7 17.2 Corporate & All Other (210.2 ) (180.3 ) (29.9 ) (16.6 ) Total Adjusted EBITDA $ 1,766.9 $ 1,506.1 $ 260.8 17.3 View source version on Contacts Investors: William S. Marshall SVP, Investor Relations (804) Media: Scott Golden Director, Communications & Engagement (804) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results
Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results

Business Wire

time20 minutes ago

  • Business Wire

Performance Food Group Company Reports Fourth-Quarter and Full-Year Fiscal 2025 Results

RICHMOND, Va.--(BUSINESS WIRE)--Performance Food Group Company ('PFG' or the 'Company') (NYSE: PFGC) today announced its fourth-quarter and full-year fiscal 2025 business results. 'Our organization finished fiscal 2025 with strong financial results driven by contributions from each of our three operating segments,' said George Holm, PFG's Chairman & Chief Executive Officer. 'I am proud of the accomplishments of our 43,000 employees, particularly our sales associates, who continue to drive share gains across our business segments. We enter fiscal 2026 with a stable industry backdrop and significant business momentum and we are on track to achieve the 3-year financial targets we announced in May. The PFG team continues to execute our strategic plan, headlined by growth, market share gains and operational execution, leading to enhanced profitability. As we progress with the integration of Cheney Brothers and José Santiago, we believe the Company will continue to create enhanced shareholder value. We are confident in our ability to achieve the fiscal 2026 targets that we announced today.' 1 This earnings release includes several metrics, including Adjusted EBITDA, Adjusted Diluted Earnings Per Share, and Free Cash Flow, that are not calculated in accordance with Generally Accepted Accounting Principles in the U.S. ('GAAP'). Please see 'Statement Regarding Non-GAAP Financial Measures' at the end of this release for the definitions of such non-GAAP financial measures and reconciliations of such non-GAAP financial measures to their respective most comparable financial measures calculated in accordance with GAAP. Expand Fourth-Quarter Fiscal 2025 Financial Summary Total case volume increased 11.9% for the fourth quarter of fiscal 2025 compared to the prior year period. Total organic case volume increased 3.9% for the fourth quarter of fiscal 2025 compared to the prior year period, benefiting from a 5.9% increase in organic independent cases and growth in cases sold to Foodservice's chain business. Total independent case volume increased 20.4%. Net sales for the fourth quarter of fiscal 2025 grew 11.5% to $16.9 billion compared to the prior year period. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Bros., Inc. ('Cheney Brothers'), an increase in cases sold including a favorable shift in the mix of cases sold, and an increase in selling price per case as a result of inflation. Overall product cost inflation for the Company was approximately 4.3% for the fourth quarter of fiscal 2025. Gross profit for the fourth quarter of fiscal 2025 grew 14.6% to $2.0 billion compared to the prior year period. The gross profit increase was driven by recent acquisitions as well as cost of goods sold optimization through procurement efficiencies, partially offset by an increase in the last-in-first-out ('LIFO') inventory reserve. Operating expenses rose 18.3% to $1.7 billion in the fourth quarter of fiscal 2025 compared to the prior year period. The increase in operating expenses was primarily driven by recent acquisitions, an increase in personnel expense primarily related to wages and salaries, commissions, and benefits, an increase in depreciation expense mainly driven by an increase in transportation equipment under finance leases, an increase in insurance expense primarily related to workers' compensation and vehicle liability, and an increase in professional fees primarily related to recent acquisitions, partially offset by a decrease in fuel expense primarily due to lower fuel prices in the fourth quarter of fiscal 2025 as compared to the prior fiscal year period. Net income for the fourth quarter of fiscal 2025 decreased $35.0 million year-over-year to $131.5 million. The decrease was primarily a result of an increase in depreciation and amortization and interest expense primarily related to recent acquisitions, partially offset by a decrease in income tax expense and gross profit contributions from recent acquisitions. The effective tax rate in the fourth quarter of fiscal 2025 was approximately 25.6% compared to 26.0% in the fourth quarter of fiscal 2024. The effective tax rate for the fourth quarter of fiscal 2025 differed from the prior year period primarily due to an increased benefit from stock-based compensation and an increase in income tax credits net of valuation allowance established, partially offset by an increase in non-deductible expenses. For the quarter, Adjusted EBITDA rose 19.9% to $546.9 million compared to the prior year period. Diluted EPS decreased 21.5% to $0.84 per share in the fourth quarter of fiscal 2025 compared to the prior year period. Adjusted Diluted EPS increased 6.9% to $1.55 per share in the fourth quarter of fiscal 2025 compared to the prior year period. Full-Year Fiscal 2025 Financial Summary Total case volume increased 8.5% for fiscal 2025 compared to the prior fiscal year. Total organic case volume increased 2.1% for fiscal 2025 compared to the prior year period, benefiting from a 4.6% increase in organic independent cases sold during fiscal 2025 and growth in cases sold to Foodservice's chain business. Total independent case volume increased 16.9%. Net sales for fiscal 2025 grew 8.6% to $63.3 billion compared to the prior fiscal year. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Brothers, an increase in cases sold including a favorable shift in mix of cases sold, and an increase in selling price per case as a result of inflation. Overall product cost inflation for the Company was approximately 4.7% for fiscal 2025. Gross profit for fiscal 2025 grew 12.8% to $7.4 billion compared to the prior fiscal year. The increase in gross profit was primarily driven by recent acquisitions, including the acquisition of Cheney Brothers, cost of goods sold optimization through procurement efficiencies, as well as a favorable shift in the mix of cases sold, including growth in the independent channel. Operating expenses rose 14.8% to $6.6 billion in fiscal 2025 compared to the prior fiscal year. The increase in operating expenses was primarily driven by recent acquisitions, including the acquisition of Cheney Brothers, increases in personnel expenses primarily related to wages and salaries, commissions, and benefits, an increase in depreciation expense mainly driven by an increase in transportation equipment under finance leases, an increase in professional fees and outside services primarily related to recent acquisitions, and an increase in insurance expense primarily related to workers' compensation and vehicle liability compared to prior year. These increases were partially offset by a decrease in fuel expense primarily due to lower fuel prices for fiscal 2025 as compared to the prior fiscal year. Net income for fiscal 2025 decreased $95.7 million year-over-year to $340.2 million driven by an increase in depreciation and amortization and interest expense primarily related to recent acquisitions, partially offset by a decrease in income tax expense and gross profit contributions from recent acquisitions. The increase in interest expense was primarily the result of an increase in average borrowings, including finance lease obligations, during fiscal 2025 compared to the prior fiscal year. The effective tax rate in fiscal 2025 was approximately 25.8% compared to 27.0% in fiscal 2024. The effective tax rate for fiscal 2025 differed from the prior fiscal year primarily due to an increased benefit from stock-based compensation and an increase in income tax credits net of valuation allowance established, partially offset by an increase in non-deductible expenses and an increase in state taxes as a percentage of income. For fiscal 2025, Adjusted EBITDA rose 17.3% to $1.8 billion compared to the prior year period. Diluted EPS decreased 21.9% to $2.18 per share in fiscal 2025 compared to the prior year period. Adjusted Diluted EPS increased 4.2% to $4.48 per share in fiscal 2025 compared to the prior year period. Cash Flow and Capital Spending In fiscal 2025, PFG provided $1,210.1 million in cash flow from operating activities compared to $1,163.0 million in cash flow from operating activities in the prior year period. The increase in cash flows provided by operating activities in fiscal 2025 compared to fiscal 2024 was largely driven by higher cash-based operating income, partially offset by changes in the timing of advanced purchases of inventory. In fiscal 2025, PFG invested $506.0 million in capital expenditures, an increase of $110.4 million versus the prior year period. In fiscal 2025, PFG delivered free cash flow of $704.1 millioncompared to free cash flow of $767.4 million in the prior year period. 1 Share Repurchase Program In November 2022, the Board of Directors of the Company authorized a share repurchase program for up to $300 million of the Company's outstanding common stock. During the three months ended June 28, 2025, the Company repurchased and subsequently retired 0.2 million shares of common stock, for a total of $13.4 million or an average cost of $75.39 per share. During the fiscal year ended June 28, 2025, the Company repurchased and subsequently retired 0.8 million shares of common stock, for a total of $57.6 million or an average cost of $75.53 per share. On May 27, 2025, the Board of Directors authorized a new share repurchase program for up to $500 million of the Company's outstanding common stock. This authorization replaces the previously authorized $300 million share repurchase program. The new share repurchase program has an expiration date of May 27, 2029 and may be amended, suspended, or discontinued at any time at the Board of Directors' discretion, subject to compliance with applicable laws. As of June 28, 2025, there remains $500 million available for additional share repurchases. Fourth-Quarter Fiscal 2025 Segment Results Foodservice Fourth-quarter fiscal 2025 net sales for Foodservice increased 20.0% to $9.2 billion compared to the prior year period. The increase in net sales was driven by recent acquisitions, including the acquisition of Cheney Brothers, case volume growth, including growth in our independent and Chain business, and an increase in selling price per case as a result of inflation. Total case growth for Foodservice was 17.4% in the fourth quarter of fiscal 2025 compared to the prior year period. New account growth and increased penetration coupled with recent acquisitions resulted in total independent case growth of 20.4% for the fourth quarter of fiscal 2025 compared to the prior year period. Organic independent case growth was 5.9% in the fourth quarter of fiscal 2025 compared to the prior year period. For the fourth quarter of fiscal 2025, independent sales as a percentage of total Foodservice sales were 41.3%. Fourth-quarter fiscal 2025 Adjusted EBITDA for Foodservice increased 26.3% to $386.9 million compared to the prior year period. The increase was the result of an increase in gross profit, partially offset by an increase in operating expenses for the fourth quarter of fiscal 2025 compared to the prior year period. Gross profit contributing to Foodservice's Adjusted EBITDA increased 24.9% driven by recent acquisitions, growth in cases sold, including more Performance Brands products sold to our independent customers, and a favorable shift in the mix of cases sold. Operating expenses impacting Foodservice's Adjusted EBITDA increased 24.4% primarily as a result of recent acquisitions, and an increase in personnel expenses compared to the prior year period. Convenience Fourth-quarter fiscal 2025 net sales for Convenience increased 2.8% to $6.4 billion compared to the prior year period. The increase in net sales for Convenience was driven by higher selling prices per case due to continued inflation, an acquisition completed in the fourth quarter of fiscal 2025, and organic case volume growth of 0.6% in the fourth quarter compared to the prior year period. Fourth-quarter fiscal 2025 Adjusted EBITDA for Convenience increased 4.8% to $120.0 million compared to the prior year period. This increase was a result of an increase in gross profit, partially offset by an increase in operating expenses. Gross profit contributing to Convenience's Adjusted EBITDA increased 3.4% for the fourth quarter of fiscal 2025 compared to the prior year period primarily driven by inventory holding gains, an acquisition completed in the fourth quarter of fiscal 2025, and a favorable shift in the mix of cases sold, partially offset by prior year releases of aged accruals. Operating expenses impacting Convenience's Adjusted EBITDA increased 2.4% in the fourth quarter of fiscal 2025 compared to the prior year period primarily as a result of an increase in personnel expenses and an acquisition completed in the fourth quarter of fiscal 2025, partially offset by a decrease in fuel expense primarily due to lower fuel prices compared to the prior year period. Specialty For the fourth quarter of fiscal 2025, net sales for Specialty increased 4.1% to $1.3 billion compared to the prior year period. This increase was primarily driven by growth in the vending, office coffee, value, and retail channels in the fourth quarter of fiscal 2025 compared to the prior year period. Total case volume growth for Specialty for the fourth quarter of fiscal 2025 was 4.2% compared to the prior year period. Fourth-quarter fiscal 2025 Adjusted EBITDA for Specialty increased 9.0% to $93.2 million compared to the prior year period. This increase was a result of an increase in gross profit, slightly offset by an increase in operating expenses. The 3.7% increase in gross profit contributing to Specialty's Adjusted EBITDA was primarily driven by sales growth and inventory holding gains, and a favorable shift in the mix of cases sold. Operating expenses impacting Specialty's Adjusted EBITDA increased 0.3% primarily due to an increase in variable expense growth in small parcel fulfillment, partially offset by a reduction in lease expense as the segment has transitioned to finance leases for fleet equipment, a decrease in fuel expense, and recovery of bad debt in the fourth quarter of fiscal 2025 compared to the prior year period. Fiscal 2026 Outlook For the first quarter of fiscal 2026, PFG expects net sales to be in a range of approximately $16.6 billion to $16.9 billion. For the first quarter of fiscal 2026, PFG expects Adjusted EBITDA to be in a range of approximately $465 million to $485 million. For the full fiscal year 2026, PFG expects net sales to be in a range of approximately $67 billion to $68 billion. For the full fiscal year 2026, PFG expects Adjusted EBITDA to be in a range of approximately $1.9 billion to $2.0 billion. PFG's Adjusted EBITDA outlook excludes the impact of certain income and expense items that management believes are not part of underlying operations. These items may include, but are not limited to, losses on early extinguishments of debt, restructuring charges, certain tax items, and charges associated with non-recurring professional and legal fees associated with acquisitions. PFG's management cannot estimate on a forward-looking basis the impact of these income and expense items on its reported net income, which could be significant, are difficult to predict, and may be highly variable. As a result, PFG does not provide a reconciliation to the closest corresponding GAAP financial measure for its Adjusted EBITDA outlook. Please see the 'Forward-Looking Statements' section of this release for a discussion of certain risks to PFG's outlook. Conference Call As previously announced, a conference call with the investment community and news media will be webcast today, August 13, 2025, at 9:00 a.m. Eastern Time. Access to the webcast is available at About Performance Food Group Company Performance Food Group is an industry leader and one of the largest food and foodservice distribution companies in North America with more than 150 locations. Founded and headquartered in Richmond, Virginia, PFG and our family of companies market and deliver quality food and related products to over 300,000 locations including independent and chain restaurants; businesses, schools and healthcare facilities; vending and office coffee service distributors; and big box retailers, theaters and convenience stores. PFG's success as a Fortune 100 company is achieved through our approximately 43,000 dedicated associates committed to building strong relationships with the valued customers, suppliers and communities we serve. To learn more about PFG, visit Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements related to our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, and integration of our acquisition of Cheney Bros., Inc. (the 'Cheney Brothers Acquisition') and other nonhistorical statements. You can identify these forward-looking statements by the use of words such as 'outlook,' 'believes,' 'expects,' 'potential,' 'continues,' 'may,' 'will,' 'should,' 'could,' 'seeks,' 'projects,' 'predicts,' 'intends,' 'plans,' 'estimates,' 'anticipates' or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. The following factors, in addition to those discussed under the section entitled Item 1A. Risk Factors in PFG's Annual Report on Form 10-K for the fiscal year ended June 29, 2024 filed with the Securities and Exchange Commission (the 'SEC') on August 14, 2024, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC's website at could cause actual future results to differ materially from those expressed in any forward-looking statements: costs and risks associated with a potential cybersecurity incident or other technology disruption; our reliance on technology and risks associated with disruption or delay in implementation of new technology, including artificial intelligence; economic factors, including inflation or other adverse changes such as a downturn in economic conditions, geopolitical events, tariff increases, or a public health crisis, negatively affecting consumer confidence and discretionary spending; our reliance on third-party suppliers; labor relations and cost risks and availability of qualified labor; competition in our industry is intense, and we may not be able to compete successfully; we operate in a low margin industry, which could increase the volatility of our results of operations; we may not realize anticipated benefits from our operating cost reduction and productivity improvement efforts; our profitability is directly affected by cost inflation and deflation, commodity volatility, and other factors; we do not have long-term contracts with certain customers; group purchasing organizations may become more active in our industry and increase their efforts to add our customers as members of these organizations; changes in eating habits of consumers; extreme weather conditions, including hurricane, earthquake and natural disaster damage and extreme heat or cold; volatility of fuel and other transportation costs; our inability to adjust cost structure where one or more of our competitors successfully implement lower costs; our inability to increase our sales in the highest margin portion of our business; changes in pricing practices of our suppliers; our growth and innovation strategy may not achieve the anticipated results; risks relating to acquisitions, including the risk that we are not able to realize benefits of acquisitions or successfully integrate the businesses we acquire or that we incur significant integration costs; a portion of our sales volume is dependent upon the distribution of cigarettes and other tobacco products, sales of which are generally declining; negative media exposure and other events that damage our reputation; impact of uncollectibility of accounts receivable; the cost and adequacy of insurance coverage and increases in the number or severity of insurance and claims expenses; the potential impacts of shareholder activists or potential bidders; the integration of artificial intelligence into our processes; environmental, health, and safety costs, including compliance with current and future environmental laws and regulations relating to carbon emissions and climate change and related legal or market measures; our inability to comply with requirements imposed by applicable law or government regulations, including increased regulation of e-vapor products and other alternative nicotine products; increase in excise taxes or reduction in credit terms by taxing jurisdictions; the potential impact of product recalls and product liability claims relating to the products we distribute and other litigation; adverse judgments or settlements or unexpected outcomes in legal proceedings; risks relating to our outstanding indebtedness, including the impact of interest rate increases on our variable rate debt; our ability to raise additional capital on commercially reasonable terms or at all; and the possibility that the expected synergies and other benefits from the Cheney Brothers Acquisition will not be realized or will not be realized within the expected time period. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC. Any forward-looking statement, including any contained herein, speaks only as of the time of this release or as of the date they were made and we do not undertake to update or revise them as more information becomes available or to disclose any facts, events, or circumstances after the date of this release or our statement, as applicable, that may affect the accuracy of any forward-looking statement, except as required by law. PERFORMANCE FOOD GROUP COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In millions) As of June 28, 2025 As of June 29, 2024 ASSETS Current assets: Cash $ 78.5 $ 20.0 Accounts receivable, less allowances of $69.0 and $55.2 2,833.0 2,478.9 Inventories, net 3,887.7 3,314.7 Income taxes receivable 96.2 71.6 Prepaid expenses and other current assets 239.7 268.1 Total current assets 7,135.1 6,153.3 Goodwill 3,480.1 2,418.3 Other intangible assets, net 1,688.5 971.1 Property, plant and equipment, net 4,458.7 2,788.5 Operating lease right-of-use assets 933.8 875.5 Other assets 185.0 186.2 Total assets $ 17,881.2 $ 13,392.9 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Trade accounts payable and outstanding checks in excess of deposits $ 3,165.3 $ 2,594.4 Accrued expenses and other current liabilities 1,025.9 908.3 Finance lease obligations—current installments 221.9 147.2 Operating lease obligations—current installments 104.5 108.2 Total current liabilities 4,517.6 3,758.1 Long-term debt 5,388.8 3,198.5 Deferred income tax liability, net 887.1 497.9 Finance lease obligations, excluding current installments 1,379.9 703.2 Operating lease obligations, excluding current installments 900.7 819.3 Other long-term liabilities 334.7 289.0 Total liabilities 13,408.8 9,266.0 Total shareholders' equity 4,472.4 4,126.9 Total liabilities and shareholders' equity $ 17,881.2 $ 13,392.9 Expand PERFORMANCE FOOD GROUP COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) Fiscal Year Ended June 28, 2025 Fiscal Year Ended June 29, 2024 Cash flows from operating activities: Net income $ 340.2 $ 435.9 Adjustments to reconcile net income to net cash provided by operating activities Depreciation and intangible asset amortization 717.9 556.7 Provision for losses on accounts receivables 22.7 19.8 Change in LIFO Reserve 88.1 62.3 Other non-cash activities 61.9 57.5 Changes in operating assets and liabilities, net: Accounts receivable (151.9 ) (81.1 ) Inventories (337.9 ) 37.7 Income taxes receivable (17.5 ) (29.9 ) Prepaid expenses and other assets 56.6 (95.8 ) Trade accounts payable and outstanding checks in excess of deposits 372.7 124.0 Accrued expenses and other liabilities 57.3 75.9 Net cash provided by operating activities 1,210.1 1,163.0 Cash flows from investing activities: Purchases of property, plant and equipment (506.0 ) (395.6 ) Net cash paid for acquisitions (2,596.4 ) (307.7 ) Proceeds from sale of property, plant and equipment and other 13.4 20.6 Net cash used in investing activities (3,089.0 ) (682.7 ) Cash flows from financing activities: Net borrowings under ABL Facility 1,194.2 6.8 Repayment of Notes due 2025 (275.0 ) Borrowing of Notes due 2032 1,000.0 — Cash paid for debt issuance, extinguishment and modifications (34.2 ) — Payments under finance lease obligations (188.0 ) (122.2 ) Net cash paid for acquisitions (1.5 ) — Proceeds from exercise of stock options and employee stock purchase plan 43.8 17.7 Cash paid for shares withheld to cover taxes (18.8 ) (21.5 ) Repurchases of common stock (57.6 ) (78.1 ) Other financing activities — (0.3 ) Net cash provided by (used in) financing activities 1,937.9 (472.6 ) Net increase in cash and restricted cash 59.0 7.7 Cash and restricted cash, beginning of period 27.7 20.0 Cash and restricted cash, end of period $ 86.7 $ 27.7 Expand The following table provides a reconciliation of cash and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows: (In millions) As of June 28, 2025 As of June 29, 2024 Cash $ 78.5 $ 20.0 Restricted cash (1) 8.2 7.7 Total cash and restricted cash $ 86.7 $ 27.7 Expand (1) Restricted cash is reported within other assets and represents the amounts required by insurers to collateralize a part of the deductibles for the Company's workers' compensation and liability claims. Expand Supplemental disclosures of cash flow information are as follows: Statement Regarding Non-GAAP Financial Measures This earnings release and the accompanying financial statement tables include several financial measures that are not calculated in accordance with GAAP, including Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow. Such measures are not recognized terms under GAAP, should not be considered in isolation or as a substitute for measures prepared in accordance with GAAP, and are not indicative of net income as determined under GAAP. Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow, and other non-GAAP financial measures have limitations that should be considered before using these measures to evaluate PFG's liquidity or financial performance. Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow, as presented, may not be comparable to similarly titled measures of other companies because of varying methods of calculation. PFG uses Adjusted EBITDA to evaluate the performance of its business on a consistent basis over time and for business planning purposes. In addition, targets based on Adjusted EBITDA are among the measures we use to evaluate our management's performance for purposes of determining their compensation under our incentive plans. PFG believes that the presentation of Adjusted EBITDA enhances an investor's understanding of PFG's performance. PFG believes this measure is a useful metric to assess PFG's operating performance from period to period by excluding certain items that PFG believes are not representative of PFG's core business. Management measures operating performance based on our Adjusted EBITDA, defined as net income before interest expense, interest income, income and franchise taxes, and depreciation and amortization, further adjusted to exclude certain items we do not consider part of our core operating results. Such adjustments include certain unusual, non-cash, non-recurring, cost reduction and other adjustment items outside of the ordinary course of the Company's operations and not indicative of ongoing performance as permitted in calculating covenant compliance under PFG's $5.0 billion secured credit facility (the 'ABL Facility') and indentures governing its outstanding notes (other than certain pro forma adjustments permitted under our ABL Facility and indentures relating to the Adjusted EBITDA contribution of acquired entities or businesses prior to the acquisition date). Under our ABL Facility and indentures, PFG's ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and making restricted payments is tied to ratios based on Adjusted EBITDA (as defined in the ABL Facility and indentures). Management also uses Adjusted Diluted EPS, which is calculated by adjusting the most directly comparable GAAP financial measure by excluding the same items excluded in PFG's calculation of Adjusted EBITDA, as well as amortization of intangible assets, to the extent that each such item was included in the applicable GAAP financial measure. For business combinations, the Company generally allocates a portion of the purchase price to intangible assets and such intangible assets contribute to revenue generation. The amount of the allocation is based on estimates and assumptions made by management and is subject to amortization over the useful lives of the intangible assets. The amount of the purchase price from an acquisition allocated to intangible assets and the term of its related amortization can vary significantly and are unique to each acquisition, and thus the Company does not believe it is reflective of ongoing operations. Intangible asset amortization excluded from Adjusted Diluted EPS represents the entire amount recorded within the Company's GAAP financial statements; whereas, the revenue generated by the associated intangible assets has not been excluded from Adjusted Diluted EPS. Intangible asset amortization is excluded from Adjusted Diluted EPS because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired, or the estimated useful life of an intangible asset is revised. Management also uses Free Cash Flow, which is defined as net cash provided by operating activities less capital expenditures (purchases of property, plant, and equipment). PFG also believes that the presentation of Free Cash Flow enhances an investor's understanding of PFG's ability to make strategic investments and manage debt levels. PFG believes that the presentation of Adjusted EBITDA, Adjusted Diluted EPS, and Free Cash Flow is useful to investors because these metrics provide insight into underlying business trends and year-over-year results and are frequently used by securities analysts, investors, and other interested parties in their evaluation of the operating performance of companies in PFG's industry. The following tables include a reconciliation of non-GAAP financial measures to the applicable most comparable GAAP financial measures. Three Months Ended (In millions, except per share data) June 28, 2025 June 29, 2024 Change % Net income (GAAP) $ 131.5 $ 166.5 $ (35.0 ) (21.0 ) Interest expense, net 94.5 57.6 36.9 64.1 Income tax expense 45.2 58.5 (13.3 ) (22.7 ) Depreciation 126.2 94.4 31.8 33.7 Amortization of intangible assets 69.4 50.4 19.0 37.7 Change in LIFO reserve (A) 49.2 11.8 37.4 316.9 Stock-based compensation expense 12.2 10.2 2.0 19.6 (Gain) loss on fuel derivatives (0.2 ) 0.5 (0.7 ) (140.0 ) Acquisition, integration & reorganization expenses (B) 11.6 4.6 7.0 152.2 Other adjustments (C) 7.3 1.7 5.6 329.4 Adjusted EBITDA (Non-GAAP) $ 546.9 $ 456.2 $ 90.7 19.9 Diluted earnings per share (GAAP) $ 0.84 $ 1.07 $ (0.23 ) (21.5 ) Impact of amortization of intangible assets 0.44 0.32 0.12 37.5 Impact of change in LIFO reserve 0.31 0.08 0.23 287.5 Impact of stock-based compensation expense 0.08 0.07 0.01 14.3 Impact of (gain) loss on fuel derivatives — — — — Impact of acquisition, integration & reorganization charges 0.07 0.03 0.04 133.3 Impact of other adjustment items 0.05 0.01 0.04 400.0 Tax impact of above adjustments (0.24 ) (0.13 ) (0.11 ) (84.6 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.55 $ 1.45 $ 0.10 6.9 Expand A. Includes increases in the LIFO inventory reserve of $5.6 million for Foodservice and $43.6 million for Convenience for the fourth quarter of fiscal 2025 compared to an increase of $4.4 million for Foodservice and an increase of $7.4 million for Convenience for the fourth quarter of fiscal 2024. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of fixed assets, and other adjustments permitted by our ABL Facility. Expand PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended (In millions, except per share data) June 28, 2025 June 29, 2024 Change % Net income (GAAP) $ 340.2 $ 435.9 $ (95.7 ) (22.0 ) Interest expense, net 358.4 232.2 126.2 54.3 Income tax expense 118.6 160.9 (42.3 ) (26.3 ) Depreciation 455.3 355.2 100.1 28.2 Amortization of intangible assets 262.6 201.5 61.1 30.3 Change in LIFO reserve (A) 88.1 62.3 25.8 41.4 Stock-based compensation expense 47.8 41.9 5.9 14.1 Loss (gain) on fuel derivatives 0.2 (1.8 ) 2.0 111.1 Acquisition, integration & reorganization expenses (B) 87.8 23.7 64.1 270.5 Other adjustments (C) 7.9 (5.7 ) 13.6 238.6 Adjusted EBITDA (Non-GAAP) $ 1,766.9 $ 1,506.1 $ 260.8 17.3 Diluted earnings per share (GAAP) $ 2.18 $ 2.79 $ (0.61 ) (21.9 ) Impact of amortization of intangible assets 1.68 1.29 0.39 30.2 Impact of change in LIFO reserve 0.56 0.40 0.16 40.0 Impact of stock-based compensation 0.31 0.27 0.04 14.8 Impact of loss (gain) on fuel derivatives — (0.01 ) 0.01 100.0 Impact of acquisition, integration & reorganization charges 0.56 0.15 0.41 273.3 Impact of other adjustment items 0.05 (0.03 ) 0.08 266.7 Tax impact of above adjustments (0.86 ) (0.56 ) (0.30 ) (53.6 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 4.48 $ 4.30 $ 0.18 4.2 Expand A. Includes increases in the LIFO inventory reserve of $6.6 million for Foodservice and $81.5 million for Convenience for fiscal 2025 compared to increases of $3.8 million for Foodservice and $58.5 million for Convenience for fiscal 2024. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes a $3.8 million gain on the sale of a Foodservice warehouse facility for fiscal year 2025 and an $8.1 million gain on the sale of a Foodservice warehouse facility for fiscal year 2024, as well as amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of other fixed assets, and other adjustments permitted by our ABL Facility. Expand (In millions) Fiscal Year Ended June 28, 2025 Fiscal Year Ended June 29, 2024 Net cash provided by operating activities (GAAP) $ 1,210.1 $ 1,163.0 Purchases of property, plant and equipment (506.0 ) (395.6 ) Free cash flow (Non-GAAP) $ 704.1 $ 767.4 Expand PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended June 28, 2025 (In millions, except per share data) Q1 Q2 Q3 Q4 Net income (GAAP) $ 108.0 $ 42.4 $ 58.3 $ 131.5 Interest expense, net 66.8 100.2 96.9 94.5 Income tax expense 38.9 14.3 20.2 45.2 Depreciation 97.4 114.1 117.6 126.2 Amortization of intangible assets 55.5 68.4 69.3 69.4 Change in LIFO reserve (A) 12.7 17.8 8.4 49.2 Stock-based compensation expense 11.3 11.7 12.6 12.2 Loss (gain) on fuel derivatives 1.4 (0.8 ) (0.2 ) (0.2 ) Acquisition, integration & reorganization expenses (B) 19.1 51.3 5.8 11.6 Other adjustments (C) 0.8 3.6 (3.8 ) 7.3 Adjusted EBITDA (Non-GAAP) $ 411.9 $ 423.0 $ 385.1 $ 546.9 Diluted earnings per share (GAAP) $ 0.69 $ 0.27 $ 0.37 $ 0.84 Impact of amortization of intangible assets 0.36 0.44 0.44 0.44 Impact of change in LIFO reserve 0.08 0.11 0.05 0.31 Impact of stock-based compensation 0.07 0.08 0.08 0.08 Impact of loss (gain) on fuel derivatives 0.01 — — — Impact of acquisition, integration & reorganization charges 0.12 0.33 0.04 0.07 Impact of other adjustment items 0.01 0.02 (0.02 ) 0.05 Tax impact of above adjustments (0.18 ) (0.27 ) (0.17 ) (0.24 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.16 $ 0.98 $ 0.79 $ 1.55 Expand A. Includes increases (decreases) in the LIFO inventory reserve of $0.9 million, ($0.1) million, $0.2 million, and $5.6 million for Foodservice and $11.8 million, $17.9 million, $8.2 million, and $43.6 million for Convenience for the first quarter, second quarter, third quarter, and fourth quarter of fiscal 2025, respectively. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes an $3.8 million gain on the sale of a Foodservice warehouse facility in the third quarter of fiscal 2025, as well as amounts related to favorable and unfavorable leases, litigation-related accruals, severance, franchise tax expense, insurance proceeds due to hurricane and other weather related events, foreign currency transaction gains and losses, gains and losses on disposals of other fixed assets, and other adjustments permitted by our ABL Facility. Expand PERFORMANCE FOOD GROUP COMPANY Non-GAAP Reconciliation (Unaudited) Fiscal Year Ended June 29, 2024 (In millions, except per share data) Q1 Q2 Q3 Q4 Net income (GAAP) $ 120.7 $ 78.3 $ 70.4 $ 166.5 Interest expense, net 56.1 61.4 57.1 57.6 Income tax expense 42.6 33.4 26.4 58.5 Depreciation 83.8 86.3 90.7 94.4 Amortization of intangible assets 45.5 57.0 48.6 50.4 Change in LIFO reserve (A) 19.2 21.8 9.5 11.8 Stock-based compensation expense 10.7 11.0 10.0 10.2 (Gain) loss on fuel derivatives (3.5 ) 1.8 (0.6 ) 0.5 Acquisition, integration & reorganization expenses (B) 9.8 3.9 5.4 4.6 Other adjustments (C) (1.1 ) (9.5 ) 3.2 1.7 Adjusted EBITDA (Non-GAAP) $ 383.8 $ 345.4 $ 320.7 $ 456.2 Diluted earnings per share (GAAP) $ 0.77 $ 0.50 $ 0.45 $ 1.07 Impact of amortization of intangible assets 0.29 0.36 0.31 0.32 Impact of change in LIFO reserve 0.12 0.14 0.06 0.08 Impact of stock-based compensation 0.07 0.07 0.06 0.07 Impact of (gain) loss on fuel derivatives (0.02 ) 0.01 — — Impact of acquisition, integration & reorganization charges 0.06 0.03 0.04 0.03 Impact of other adjustment items — (0.06 ) 0.02 0.01 Tax impact of above adjustments (0.14 ) (0.15 ) (0.14 ) (0.13 ) Adjusted Diluted Earnings per Share (Non-GAAP) $ 1.15 $ 0.90 $ 0.80 $ 1.45 Expand A. Includes increases (decreases) in the LIFO inventory reserve of $1.7 million, ($1.1) million, ($1.2) million, and $4.4 million for Foodservice and $17.5 million, $22.9 million, $10.7 million, and $7.4 million for Convenience for the first quarter, second quarter, third quarter, and fourth quarter of fiscal 2024, respectively. B. Includes professional fees and other costs related to in-progress, completed, and abandoned acquisitions, costs of integrating certain of our facilities, and facility closing costs. C. Includes an $8.1 million gain on the sale of a Foodservice warehouse facility in second quarter of fiscal 2024, as well as asset impairments, insurance proceeds due to hurricane and other weather related events, amounts related to favorable and unfavorable leases, foreign currency transaction gains and losses, franchise tax expense, and other adjustments permitted by our ABL Facility. Expand Segment Results In the third quarter of fiscal 2025, the Company updated its operating segments to reflect the manner in which the business is managed. The Company continues to have three reportable segments: Foodservice, Convenience, and Specialty (formerly Vistar). Management evaluates the performance of these segments based on various operating and financial metrics, including their respective sales growth and Segment Adjusted EBITDA, which is the Company's GAAP measure of segment profit. Segment Adjusted EBITDA is defined as net income before interest expense, interest income, income taxes, depreciation, and amortization and excludes certain items that the Company does not consider part of its segments' core operating results, including stock-based compensation expense, changes in the LIFO reserve, acquisition, integration and reorganization expenses, and gains and losses related to fuel derivatives. Corporate & All Other is comprised of corporate overhead and certain operations that are not considered separate reportable segments based on their size. The presentation and amounts for the three months and fiscal year ended June 29, 2024 have been recast to reflect the updated segments. The following tables set forth net sales and Segment Adjusted EBITDA by segment and the reconciling items for Corporate & All Other and eliminations for the periods indicated (dollars in millions): Net Sales Three Months Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 9,191.5 $ 7,661.1 $ 1,530.4 20.0 Convenience 6,436.3 6,258.5 177.8 2.8 Specialty 1,253.5 1,203.7 49.8 4.1 Total Segments $ 16,881.3 $ 15,123.3 $ 1,758.0 11.6 Corporate & All Other 256.9 238.1 18.8 7.9 Intersegment Eliminations (199.3 ) (172.2 ) (27.1 ) (15.7 ) Total net sales $ 16,938.9 $ 15,189.2 $ 1,749.7 11.5 Expand Fiscal Year Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 33,646.1 $ 29,061.5 $ 4,584.6 15.8 Convenience 24,507.5 24,177.0 330.5 1.4 Specialty 4,905.0 4,789.8 115.2 2.4 Total Segments $ 63,058.6 $ 58,028.3 $ 5,030.3 8.7 Corporate & All Other 955.0 909.2 45.8 5.0 Intersegment Eliminations (714.7 ) (656.3 ) (58.4 ) (8.9 ) Total net sales $ 63,298.9 $ 58,281.2 $ 5,017.7 8.6 Expand Segment Adjusted EBITDA Three Months Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 386.9 $ 306.3 $ 80.6 26.3 Convenience 120.0 114.5 5.5 4.8 Specialty 93.2 85.5 7.7 9.0 Total Segments $ 600.1 $ 506.3 $ 93.8 18.5 Corporate & All Other (53.2 ) (50.1 ) (3.1 ) (6.2 ) Total Adjusted EBITDA $ 546.9 $ 456.2 $ 90.7 19.9 Expand Fiscal Year Ended June 28, 2025 June 29, 2024 Change % Foodservice $ 1,221.6 $ 982.2 $ 239.4 24.4 Convenience 407.3 363.6 43.7 12.0 Specialty 348.2 340.6 7.6 2.2 Total Segments $ 1,977.1 $ 1,686.4 $ 290.7 17.2 Corporate & All Other (210.2 ) (180.3 ) (29.9 ) (16.6 ) Total Adjusted EBITDA $ 1,766.9 $ 1,506.1 $ 260.8 17.3 Expand

SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results
SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results

Business Wire

time20 minutes ago

  • Business Wire

SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (NASDAQ: SBC, 'SBC Medical' or the 'Company'), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the second quarter of fiscal year 2025 (three months ended June 30, 2025) and for the first half of fiscal year 2025 (six months ended June 30, 2025). Second Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $15 million, representing a 47% year-over-year decrease. Net Income attributable to SBC Medical Group was $2.5 million, representing an 87% year-over-year decrease. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.02 for the three months ended June 30, 2025, compared to $0.20 in the same period of 2024. EBITDA 1, which is calculated by adding depreciation and amortization expense and impairment loss to income from operations was $15 million, representing a 46% year-over-year decrease. EBITDA margin 1 was 35% for the second quarter of 2025, compared to 53% for second quarter of 2024. Return on equity, which is defined as net income attributable to the Company divided by the average of shareholder's equity as of June 30, 2025, was 4% representing a year-over-year decrease of 44 percentage points. Number of Franchise Locations 2 was 259 as of June 30, 2025, representing an increase of 36 locations from June 30, 2024. Number of customers 3 in the last twelve months ended June 30, 2025, was 6.31 million, representing a 14% year-over-year increase. Repeat rate for customers 4 who visited franchisee's clinics twice or more was 72%. Total revenues were $91 million, representing a 16% year-over-year decrease. Income from operations was $39 million, representing a 25% year-over-year decrease. Net Income attributable to SBC Medical Group was $24 million, representing a 36% year-over-year decrease. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.23 for the six months ended June 30, 2025, compared to $0.40 in the same period of 2024. EBITDA 1, which is calculated by adding depreciation and amortization expense and impairment loss to income from operations was $40 million, representing a 25% year-over-year decrease. EBITDA margin 1 was 44% for the first half of 2025, compared to 50% for first half of 2024. Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, said, ' As anticipated and signaled in our prior guidance, Q2 2025 reflected strategic shifts aimed to position SBC Medical for long-term competitiveness and scalability. Total revenue declined 18% year-over-year to $43 million, primarily due to the completed discontinuation of our staffing business, targeted divestitures to streamline our operations, and revision of fee structure. We are executing our strategic plan with precision, as evidenced by our network of 259 Franchise Locations as of June 30, 2025 and 6.31 million visits over the last twelve months, demonstrating a scale that is unmatched in Japan. Our high repeat rate underscores the strength of our Shonan Beauty Clinic brand. Japan's consumer discretionary market faces challenges, including restrained growth due to trade restrictions and cautious consumer spending. Despite these headwinds, we are successfully advancing key initiatives, including the acquisition of MB career lounge to enhance our management support services and the joining of JUN CLINIC to our network, which boasts a high average spend per customer. Looking ahead, we remain confident in our strategic roadmap, focused on optimizing our franchise model, capturing growth opportunities, transitioning to higher-margin models, and delivering lasting value to our shareholders.' Second Quarter 2025 Financial Results Total revenues were $43 million, a decrease of 18% year-over-year, primarily due to a revised fee structure for franchising services implemented starting from April 2025, the discontinuation staffing services business, and divestiture of SNA and Kijimadaira, partially offset by growth in procurement, rental services, and other revenue streams. Net income attributable to SBC Medical Group for the three months ended June 30, 2025 was $2.5 million, compared to $18.5 million in the same period of 2024. The decrease was largely attributed to unfavorable changes in other income and expenses, primarily due to higher foreign exchange losses. EBITDA 1 was $15 million, a decrease of 46% year-over-year, primarily due to lower revenue following the termination of the staffing services business, the deconsolidation of SNA and Kijimadaira, and revision of fee structure. Conference Call The Company will hold a conference call on Wednesday, August 13, 2025 at 8:30 am Eastern Time (or Wednesday, August 13, 2025 at 9:30 pm Japan Time) to discuss the financial results and take questions live. Please register in advance of the conference using the link provided below. It will automatically direct you to the registration page of 'SBC Q2 2025 Financial Results Presentation.'. Please follow the steps to enter your registration details, then click 'Submit.'. Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well as past investor relations materials. Starting 10 minutes before the conference call begins, you will be able to view the earnings presentation materials on the site. The materials will also be available for download. A replay of the conference call will be accessible until August 13, 2026. Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company's Investor Relations website at About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchise clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchise clinic customers, assistance with franchise employee housing rentals and facility rentals, construction and design of franchise clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchise clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchise clinic's customer rewards program (customer loyalty point program), and payment tools for the franchise clinics. For more information, visit Use of Non-GAAP Financial Measures The Company uses non-GAAP measures, such as EBITDA and EBITDA margin, in evaluating its operating results and for financial and operational decision-making purposes. The Company believes that the non-GAAP financial measures help identify underlying trends in its business. The Company believes that the non-GAAP financial measures provide useful information about the Company's results of operations, enhance the overall understanding of the Company's past performance and future prospects and allow for greater visibility with respect to key metrics used by the Company's management in its financial and operational decision-making. The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools, and when assessing the Company's operating performance, cash flows or liquidity, investors should not consider them in isolation, or as a substitute for net loss, cash flows provided by operating activities or other consolidated statements of operations and cash flows data prepared in accordance with U.S. GAAP. The Company mitigates these limitations by reconciling the non-GAAP financial measures to the most comparable U.S. GAAP performance measures, all of which should be considered when evaluating the Company's performance. For more information on the non-GAAP financial measures, please see the table captioned 'Unaudited Reconciliations of GAAP and Non-GAAP Results.' Forward Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's financial performance; growth in revenue and earnings; business prospects and opportunities; and capital deployment plans and liquidity. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at SBC MEDICAL GROUP HOLDINGS INCORPORATED UNAUDITED CONSOLIDATED BALANCE SHEETS June 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 152,740,882 $ 125,044,092 Accounts receivable 2,350,368 1,413,433 Accounts receivable – related parties 48,920,843 28,846,680 Inventories 1,705,237 1,494,891 Finance lease receivables, current – related parties 9,128,931 5,992,585 Customer loans receivable, current 10,552,623 10,382,537 Prepaid expenses and other current assets 14,051,746 11,276,802 Other receivables – related parties 1,891,408 — Total current assets 241,342,038 184,451,020 Non-current assets: Property and equipment, net 8,058,016 8,771,902 Intangible assets, net 1,584,543 1,590,052 Long-term investments, net 3,593,087 3,049,972 Goodwill, net 5,011,511 4,613,784 Cryptocurrencies 535,882 — Finance lease receivables, non-current – related parties 13,197,979 8,397,582 Operating lease right-of-use assets 4,583,393 5,267,056 Finance lease right-of-use assets 516,932 — Deferred tax assets 2,343,302 9,798,071 Customer loans receivable, non-current 5,934,636 5,023,551 Long-term prepayments 1,755,292 1,745,801 Long-term investments in MCs – related parties 19,381,422 17,820,910 Other assets 7,461,224 15,553,453 Total non-current assets 73,957,219 81,632,134 Total assets $ 315,299,257 $ 266,083,154 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 16,290,206 $ 13,875,179 Accounts payable – related parties 3,245,989 659,044 Current portion of long-term loans 69,420 96,824 Notes and other payables, current – related parties 3,272,048 26,255 Advances from customers 512,123 820,898 Advances from customers – related parties 10,333,007 11,739,533 Income tax payable 14,133,163 18,705,851 Operating lease liabilities, current 3,623,871 4,341,522 Finance lease liabilities, current 161,340 — Accrued liabilities and other current liabilities 6,229,797 8,103,194 Due to related party 2,810,647 2,823,590 Total current liabilities 60,681,611 61,191,890 Expand June 30, 2025 December 31, 2024 Non-current liabilities: Long-term loans 7,031,506 6,502,682 Notes and other payables, non-current – related parties — 5,334 Deferred tax liabilities 353,517 926,023 Operating lease liabilities, non-current 1,208,516 1,241,526 Finance lease liabilities, non-current 164,721 — Other liabilities 1,206,815 1,193,541 Total non-current liabilities 9,965,075 9,869,106 Total liabilities 70,646,686 71,060,996 Stockholders' equity: Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024) — — Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 and 103,020,816 shares issued, 103,098,442 and 102,750,816 shares outstanding as of June 30, 2025 and December 31, 2024, respectively) 10,388 10,302 Additional paid-in capital 72,196,114 62,513,923 Treasury stock (at cost, 782,809 and 270,000 shares as of June 30, 2025 and December 31, 2024, respectively) (5,115,262 ) (2,700,000 ) Retained earnings 213,423,693 189,463,007 Accumulated other comprehensive loss (35,922,942 ) (54,178,075 ) Total SBC Medical Group Holdings Incorporated stockholders' equity 244,591,991 195,109,157 Non-controlling interests 60,580 (86,999 ) Total stockholders' equity 244,652,571 195,022,158 Total liabilities and stockholders' equity $ 315,299,257 $ 266,083,154 Expand The accompanying notes are an integral part of these unaudited consolidated financial statements. COMPREHENSIVE INCOME For the Three Months Ended June 30, For the Six Months Ended June 30, 2025 2024 2025 2024 Revenues, net – related parties $ 38,944,898 $ 51,039,038 $ 84,202,043 $ 101,509,245 Revenues, net 4,413,949 2,063,042 6,485,505 6,400,877 Total revenues, net 43,358,847 53,102,080 90,687,548 107,910,122 Cost of revenues (including cost of revenues from related parties of $4,669,602 and $3,616,103 for the three months ended June 30, 2025 and 2024, and $8,126,530 and $5,413,462 for the six months ended June 30, 2025 and 2024, respectively) 13,348,270 13,682,405 22,943,887 28,971,072 Gross profit 30,010,577 39,419,675 67,743,661 78,939,050 Operating expenses: Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of $415,767 and nil for the three months ended June 30, 2025 and 2024, and $415,767 and nil for the six months ended June 30, 2025 and 2024, respectively) 15,456,385 12,129,115 28,987,395 27,187,605 Total operating expenses 15,456,385 12,129,115 28,987,395 27,187,605 Income from operations 14,554,192 27,290,560 38,756,266 51,751,445 Other income (expenses): Interest income 22,882 11,644 78,215 29,333 Interest expense (49,651 ) (7,424 ) (55,858 ) (10,432 ) Other income 33,771 306,291 185,099 655,972 Other expenses (1,132,465 ) (514,636 ) (2,829,724 ) (1,951,292 ) Gain on redemption of life insurance policies — — 8,746,138 — Change in fair value of cryptocurrencies 111,632 — 111,632 — Gain on disposal of subsidiary — — — 3,813,609 Total other income (expenses) (1,013,831 ) (204,125 ) 6,235,502 2,537,190 Income before income taxes 13,540,361 27,086,435 44,991,768 54,288,635 Income tax expense 11,100,509 8,529,110 21,059,966 16,981,094 Net income 2,439,852 18,557,325 23,931,802 37,307,541 Less: net income (loss) attributable to non-controlling interests (18,388 ) 72,917 (28,884 ) 65,381 Net income attributable to SBC Medical Group Holdings Incorporated $ 2,458,240 $ 18,484,408 $ 23,960,686 $ 37,242,160 Other comprehensive income (loss): Foreign currency translation adjustment $ 8,623,269 $ (9,046,549 ) $ 18,431,596 $ (19,240,401 ) Total comprehensive income 11,063,121 9,510,776 42,363,398 18,067,140 Less: comprehensive income (loss) attributable to non-controlling interests 184,411 22,000 147,579 (70,000 ) Comprehensive income attributable to SBC Medical Group Holdings Incorporated $ 10,878,710 $ 9,488,776 $ 42,215,819 $ 18,137,140 Net income per share attributable to SBC Medical Group Holdings Incorporated* Basic and diluted $ 0.02 $ 0.20 $ 0.23 $ 0.40 Weighted average shares outstanding* Basic and diluted 103,507,249 94,192,433 103,392,580 94,192,433 Expand * Retrospectively restated for effect of reverse recapitalization on September 17, 2024. Expand The accompanying notes are an integral part of these unaudited consolidated financial statements. SBC MEDICAL GROUP HOLDINGS INCORPORATED UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS For the Six Months Ended June 30, 2025 2024 CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 23,931,802 $ 37,307,541 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization expense 1,264,405 1,849,422 Non-cash lease expense 2,185,744 1,923,890 Provision for credit losses 283,752 62,804 Fair value change of long-term investments 384,523 1,045,557 Gain on disposal of subsidiary — (3,813,609 ) Gain on redemption of life insurance policies (8,746,138 ) — Gain on disposal of property and equipment (10,804 ) (902 ) Change in fair value of cryptocurrencies (111,632 ) — Deferred income taxes 7,452,983 (3,322,728 ) Changes in operating assets and liabilities: Accounts receivable (789,577 ) (1,423,412 ) Accounts receivable – related parties (17,039,113 ) 5,843,499 Inventories (717,972 ) 561,921 Finance lease receivables – related parties (6,482,967 ) (1,759,556 ) Customer loans receivable 8,081,703 7,521,267 Prepaid expenses and other current assets (1,349,225 ) (1,488,347 ) Long-term prepayments 211,988 (41,412 ) Other assets 85,907 (1,007,431 ) Accounts payable 1,165,217 (8,960,556 ) Accounts payable – related parties 2,455,865 — Notes and other payables – related parties (5,031,570 ) (5,101,368 ) Advances from customers (369,616 ) (755,977 ) Advances from customers – related parties (2,363,891 ) (4,663,233 ) Income tax payable (6,030,526 ) 5,462,133 Operating lease liabilities (2,275,398 ) (1,998,196 ) Accrued liabilities and other current liabilities (2,508,035 ) (4,444,172 ) Other liabilities (88,593 ) 77,625 (6,411,168 ) 22,874,760 CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property and equipment (560,431 ) (1,565,333 ) Purchase of convertible note — (1,700,000 ) Prepayments for property and equipment (705,351 ) — Advances to related parties — (617,804 ) Payments made on behalf of related parties (1,836,541 ) (5,245,990 ) Purchase of long-term investments (652,555 ) — Purchase of cryptocurrencies (424,250 ) — Long-term loans to others (13,134 ) (62,489 ) Repayments from related parties 70,000 555,000 Repayments from others 56,307 44,748 Proceeds from redemption of life insurance policies 17,735,717 — Disposal of subsidiary, net of cash disposed of — (815,819 ) Proceeds from disposal of property and equipment 1,728,236 1,971 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 15,397,998 (9,405,716 ) Expand SBC MEDICAL GROUP HOLDINGS INCORPORATED UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued) The accompanying notes are an integral part of these unaudited consolidated financial statements. Unaudited Reconciliations of GAAP and Non-GAAP Results The accompanying notes are an integral part of these unaudited consolidated financial statements.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store